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ABSTRACT 
Children exposed to alcohol during gestation are at risk of developing a spectrum of 
neurodevelopmental disorders known as fetal alcohol spectrum disorders (FASD). The 
most severe form of this disorder is fetal alcohol syndrome (FAS), which is characterised 
by neurological deficits, facial dysmorphogenesis and growth retardation. Most research 
is on neurological deficits and facial dysmorphogenesis, with less attention given to the 
effects of gestational alcohol exposure on the skeletal system. Therefore, this study 
investigated the effects of prenatal alcohol exposure on bone growth and development 
in a postnatal three week old Sprague-Dawley rats tibia using immunohistochemical and 
three dimensional microfocus x-ray computed tomography (µCT) investigations.  
Female Sprague-Dawley rats (n=15) were time-mated and divided in to three groups as 
follows: (i) the ethanol group (n=6) received 0.015 ml/g body weight of 25.2% alcohol for 
19 days, (ii) the saline control group (n=6) received the same dose of 0.9% saline for the 
same period and (iii) the untreated control group (n=3) received neither ethanol nor 
saline. Two Pups (n=30) from each dam (n=30} were randomly selected and terminated 
on day 21 after delivery and bilateral tibiae (n=60) were dissected, fixed, decalcified, 
processed and then subjected to histological and immunohistochemistry staining as well 
as µCT.  
The growth plate surface area was significantly smaller with fewer cell number in 
proliferative and hypertrophic zones in the ethanol group.  There were also fewer Ki-67 
labelled cells recorded in the ethanol group. However, the full and shaft length of the 
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tibia were similar among all three groups in the study. We found both lower bone volume 
to total volume (BV/TV) and trabecular thickness (TbTh) to be lower in the ethanol group 
in comparison with the controls. The trabecular number (TbN) was not affected in our 
study. However, there was more trabecular spacing in the ethanol group.  
This, considered together with the lower BV/TV and TbTh suggests that, although the 
bone length was similar in all groups, the internal morphology was not the same among 
the study groups. This indicates that prenatal alcohol exposure at our dosage may affect 
internal architecture while sparing the external bone length. This disruption of the 
internal bone morphology may also explain why FAS children are prone to osteoporosis 
and fracture as they may have less bony material internally. 
Employing a binary logistic regression showed that the distal medullary canal area and 
trabecular spacing were the main parameters that determined group membership into 
either ethanol treated or saline control. This means that these two are affected the most 
in gestational alcohol exposure. 
Our finding of a positive correlation between medullary canal area and cortical thickness 
indicates that the smaller medullary canal was coupled with thinner cortical bone. We 
propose that this may potentially explain weaker bones observed in FAS children. 
In the ethanol group, trabecular thickness and spacing had negative loadings to the 
principal component analysis model. These two parameters were also negatively 
correlated. This suggests that trabecular formation may have been delayed in the 
ethanol group. 
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Gestational alcohol exposure had an adverse effect on the growth plate with respect to 
its general size, respective zone sizes and the number of cells in each zone. This may be 
how diminished stature of the offspring occurs. Fewer proliferative cells were found 
using the anti-Ki67 antibody, indicating that in utero alcohol exposure slows cell 
proliferation, contributing to the small stature.  
Logistic regression showed that the distal medullary canal area and trabecular separation 
were the main parameters affected the most in gestational alcohol. The negative 
correlation of trabecular thickness and spacing in the ethanol group may be a contributor 
to bone weakness. These findings add new knowledge to how in utero alcohol exposure 
affects the offspring. 
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STRUCTURE OF THE DISSERTATION 
The dissertation was written in four chapters. In the first chapter, a general introduction 
on FAS were provided. Moreover, the aims and objectives of the study, justifications as 
well as the hypothesis were explained. The chapter also covered the literature review of 
the related topic, rate of alcohol consumption among pregnant women as well as 
prevalence and features of FAS. It also covered bone development and the mechanisms 
by which intrauterine alcohol exposure affects bone development. 
The second chapter explained the materials and methodology applied in the study. It 
explained in details the procedures and protocols involved in immunohistochemistry and 
the three-dimensional micro-focus x-ray computed tomography investigations. 
The result of the study were presented in chapter three, while the discussion, conclusion, 
limitations of the study as well as recommendations were presented in chapter four.  
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1 GENERAL INTRODUCTION 
Alcohol is a teratogenic agent and is the second most widely used psychoactive 
substance worldwide (Zakhari and Li, 2007). Despite an awareness of the deleterious 
effects of alcohol consumption, acute and chronic alcoholism is increasing among old 
and young populations including pregnant women (Chen et al., 2001). The rate at which 
pregnant women of child bearing age consume alcohol is increasing (20%), worldwide 
(Chang et al., 2000). Alcohol consumption at this stage can result in a variety of disorders 
to the developing fetus, collectively referred to as fetal alcohol spectrum disorders 
(FASD). These may include fetal alcohol syndrome (FAS), which is the most severe and 
extreme end of the spectrum of these disorders. It (FAS) is the commonest cause of 
growth retardation in the Western world (Medina, 2011). It is also associated with 
persistent physical and neurodevelopmental abnormalities across all socioeconomic 
groups, races and ethnicities. The incidence of FAS is increasing, making alcohol use 
during pregnancy an important public health concern among women and their unborn 
children (Ramadoss et al., 2006).   
Fetal alcohol syndrome is characterised by growth and mental retardation, facial 
dysmorphogenesis and neurodevelopmental abnormalities (Ernhart et al., 1985; 
O`Leary, 2004; Simpson et al., 2005; Carvalho et al., 2016). Although it is difficult to 
diagnose at early age growth retardation remains the cardinal feature of FAS (Day, 1992; 
Ramadoss et al., 2006). 
 
 
 
2 
 
Several studies investigating the effects of gestational alcohol on the prenatal 
development of the osseous tissue to understand the resultant growth retardation exist 
in the literature (Miralles‐Flores and Delgado‐Baeza, 1992; Keiver et al., 1997). In 
contrast, studies on these in utero alcohol effects in postnatal development of the 
osseous tissue are limited (Miralles-Flores and Delgado-Baeza, 1992; Nwaogu, 2002). The 
mechanisms involved in the observed growth retardation following gestational alcohol 
exposure are still unclear, which warrants further investigations.  
1.2 AIMS AND OBJECTIVES 
1.2.1 Aims   
This study aims to determine the effects of prenatal alcohol exposure on the distal 
growth plate of postnatal three-week-old Sprague-Dawley rat tibia.  
1.2.2 Objectives of the present study 
1. To test whether gestational alcohol exposure affects the tibial growth plate.  
2. To investigate whether gestational alcohol exposure affects cellular proliferation 
in the tibial growth.  
3. To investigate whether gestational alcohol exposure affects internal tibial bone 
morphology. 
The result of this study could go a long way in adding knowledge to the field of research 
as well as a tool for further research. It could also add clinical information on how 
prenatal alcohol exposure can lead to osteoporosis with subsequent pathological 
fracture.  
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1.3 LITERATURE REVIEW 
1.3.1 Fetal alcohol syndrome (FAS) 
Maternal alcohol ingestion adversely affects the developing fetus in various ways such 
as spontaneous abortion, intrauterine fetal death, asphyxia, low birth weight, and 
perinatal mortality (Carvalho et al., 2016). A spectrum of disorders which include: fetal 
alcohol syndrome, partial fetal alcohol syndrome, alcohol related neurodevelopmental 
disorder, and alcohol-related birth defects. Also associated with these adverse effects 
are collectively referred to as fetal alcohol spectrum disorder, with fetal alcohol 
syndrome being the most severe form of the disorder (Ethen et al., 2009). 
Lemoine (2003) first described the pattern of disabilities associated with prenatal alcohol 
exposure in France in 1968. The name, Fetal alcohol syndrome was first documented in 
1973 by Jones and Smith in United States (Urban et al., 2008). This condition is 
characterised by a pattern of pre and postnatal growth retardation, facial 
dysmorphology and central nervous system deficits. These features can appear in milder 
forms in some exposed children who may not be diagnosed with fetal alcohol syndrome. 
Therefore, the consequences of prenatal alcohol exposure ranges from mild effects to 
full blown features of fetal alcohol syndrome (Larkby and Day, 1997). The subtle nature 
and lack of accurate knowledge of associated features in neonates and infants makes 
diagnosis of fetal alcohol syndrome difficult and often missed during these early life 
periods. Due to the complexity and range of dysfunctions linked to prenatal alcohol 
exposure, a multidisciplinary approach is required to achieve accurate diagnosis and 
treatment recommendations (Chudley et al., 2005). 
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Alcohol consumption in pregnancy 
Manifestation of full blown features of FAS is dependent on the timing, dosing and 
maternal drinking pattern. Research shows an increase in alcohol use among pregnant 
women worldwide (Olegård et al., 1979; Larkby and Day, 1997; Croxford and Viljoen, 
1999; Ornoy and Ergaz, 2010). In the United States of America, the center for disease 
control and prevention (CDC) reported a rate increase from 12.4% in 1991 to 16.3% in 
1995. In South Africa, a study in rural and urban areas of the Western Cape Province 
shows that 42.8% of the women admitted to varying degrees of alcohol consumption 
during pregnancy. Some (23.7%) were regarded as significant drinkers (moderate or 
heavy alcohol drinking in a binge pattern) (Croxford and Viljoen, 1999).  
The term pregnancy risk-drinking is defined as the consumption of one ounce or more of 
alcohol (two or more drinks) per day (Chang, 2001). The following general definitions of 
drinking pattern is therefore used to identify harmful effects of alcohol consumption:  
(i) binge drinking (≥4 drinks per occasion for women and ≥5 drinks per occasion 
for men),  
(ii) heavy drinking (>1 drink per day on average for women, and >2 drinks per day 
on average for men),  
(iii) any alcohol consumption by youth aged < 21 years, and any alcohol 
consumption by pregnant women.  
These definitions are consistent with what is obtainable from CDC and the National 
Institute on Alcohol Abuse and Alcoholism (Bouchery et al., 2011).  
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While heavy drinking in pregnancy is known for its adverse effects on the offspring, small 
amounts of alcohol intake (0.5 drinks per day) may also have adverse effects (Sokol et 
al., 1980). This was observed in a study at Yale-New Haven Hospital that reported an 
association between intrauterine growth retardation (birth weight less than the 10th 
percentile for each gestational week) and mild alcohol ingestion (>0.10 to 0.25 ounce) 
during pregnancy (Lundsberg et al., 1997). These studies indicate that there is no 
universally accepted safe amount of alcohol use during pregnancy.  However, the 
severity of these effects tends to be proportional to the amount of alcohol consumed 
(Windham et al., 1995).  
Features of FAS and diagnostic criteria  
In recent years, diagnosis of FAS has undergone a series of modification since its ealier 
description by Jones and colleagues in 1973. The main challenge is that there is no 
standard laboratory tests for the diagnosis of FAS. As a result, different diagnostic criteria 
are used in delineating  the features of FAS (May et al., 2014). 
Although these criteria differ in mode of diagnosis, they share similar definitions of FAS 
features. These are: pre or postnatal growth retardation, facial abnormalities (short 
palpebral fissure, indistinct philtrum, short nose, epicanthic folds, depressed nasal 
bridge, thin vermillion, and micrognathia) and central nervous system abnormalties 
(mental retardation, behavioural problems, poor concentration and attention, social 
withdrawal and conduct problems) (Riley et al., 2011). These features have been defined 
by four different diagnostic criteria which include: 4-digits code, revised-institute of 
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medicine (IOM), Canadian guidelines for diagnosis, national task force/CDC guidelines 
(Table 1.1) (Riley et al., 2011). However, diagnosis require a history of maternal alcohol 
ingestion (O'Leary, 2004).  
1.3.2 Prevalence of FAS 
Varying research methods  
Studies determining the prevalence of FAS encountered several challenges such as, case 
finding, sampling, diagnostic criteria, variation in methodology, and coordination of 
interdisciplinary activities (May et al., 2009). Moreover, surveillance systems: prenatal 
clinic-based studies and special referral clinics have been proven to be inadequate in 
determining the prevalence of FAS. The inadequacy may be associated with a lack of 
standard diagnostic criteria, and denial of history of maternal alcohol ingestion (May et 
al., 2014).  
Due to these challenges, estimating the prevalence of FAS varies from one country to 
another and between geographical and cultural settings of communities within the same 
country (May and Gossage, 2001). These considerable variations among different 
countries make reliably estimating the global prevalence of FAS difficult (Roozen et al., 
2016). 
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Table 1.1: Summary of various diagnostic criteria of FAS and definition of clinical features.  
Features of 
FAS 
4-digits code Revised IOM Canadian 
guidelines 
National task 
force/CDC 
Growth  
retardation 
Height and 
weight below 
the 10th 
percentile for 
age.  
Height and 
weight below 
the 10th 
percentile for 
age.  
Height and 
weight below 
the 10th 
percentile for 
age or low 
weight to 
heigth ratio. 
Height and weight 
less than the 10th 
percentile at any 
point in time. 
Facial 
abnormalities 
Presence of the 
following: short 
palpebral 
fissure, thin 
vermillion 
border and 
indistinct 
philtrum. 
Presence of two 
or more of the 
following 
features: short 
palpebral 
fissure, thin 
vermillion 
border and 
indistinct 
philtrum. 
Presence of the 
following: short 
palpebral 
fissure, thin 
vermillion 
border and 
indistinct 
philtrum. 
Presence of the 
following: short 
palpebral fissure, 
thin vermillion 
border and 
indistinct philtrum. 
CNS 
anomalies 
Occipitofrontal 
circumfrence 
(OFC) below 
normal (≤2 SD) 
or significant 
brain 
abnormalites or 
function. 
OFC less than 
the 10th 
percentile or 
presence of 
structural brain 
abnormality. 
CNS 
impairment: 
brain sructure; 
cognition; 
communication; 
academic 
performance; 
memory; 
abstract  
OFC below the 10th 
percentile or 
structural brain 
abnormality. 
 
 
Various epidemiological methods are used worldwide to delineate the prevalence of FAS. 
The three main methods are: passive method (use of birth certificates and special 
registry); clinical based studies (screening of pregnant women for alcohol abuse and 
follow-up) and active case ascertainment method (targets referrals of all children with 
FAS) (Warren et al., 2001). Of these methods, the passive method, which relies on pre-
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existing health records is less expensive and less time consuming. However, this method 
is associated with lack of general consistency due to its overdependence on the quality 
and completeness of the existing births and special registries, as well as diagnostic efforts 
of non-specialist and other health care providers (May et al., 2009).  
In contrast, the active case ascertainment method provides active, effective and 
comprehensive focus on a specific population at a particular geographical location (May 
and Gossage, 2001). Compared to other methods, the active case ascertainment method 
provides the best coverage of FAS. This method also allows active recruitment and case 
finding of children with FAS (May et al., 2009). 
Prevalence of FAS in developed countries 
In the United States, the CDC’s Birth Defects Monitoring Program reported a prevalence 
of 0.2 per 1000 live births from 1979 to 1992. A higher rate of 0.3 and 0.67 per 1000 live 
births was reported between 1992 and 1993. The rate varies between ethnic groups 
from 1981 to 1986 as follows: 0.6 per 1000 live births among African-Americans, 0.08 
among Hispanics, 2.9 among American-Indians, 0.03 among Asians, and 0.09 among 
whites (May et al., 2009). A relatively recent study conducted using the active case 
ascertainment method in a Midwestern community among first grade students (6 to 7 
years old) reported a rate of 6 to 9 per 1000 children (May et al., 2014). Generally, the 
most widely accepted prevalence is 0.97 per 1000. This is the representation of the 
combined averages from various prospective studies in the country (Warren et al., 2001). 
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In Australia, a comprehensive estimate was obtained from a combined data from the 
Western Australia Birth Defects and Rural Pediatric Services. The findings reported a 
prevalence of 0.02 per 1000 live births for the non-Aboriginal children, and 2.76 per 1000 
live births for the Aboriginal children. In the Northern Territory, data obtained from 
retrospective study of medical records and outpatient correspondence of children born 
from 1999 to 2000 showed a prevalence of 0.68 per 1000 live births. Likewise, an average 
rate of  between 1.87 and 4.7 per 1000 live births for indigenous children was found 
(May and Gossage, 2001). 
In Canada, there is no standard national statistics on the prevalence of FAS. However, 
different studies estimated the rate from different communities of British Columbia, 
Manitoba, and Saskatchewan. In British Columbia and Manitoba, the prevalence is 190 
per 1000 and 55 to 101 per 1000 live births respectively. Based on referral to the 
diagnostic centers, the rate was estimated to be 0.589 per 1000 live births in 
Saskatchewan (Chudley et al., 2005).  
Prevalence of FAS in South Africa 
There is no standard national surveillance system to determine the nationwide 
prevalence of FAS in South Africa. However research has been conducted in this area, 
and different researchers have documented a high prevalence of FAS from various 
communities in different provinces of the country (Viljoen et al., 2005; May et al., 2013; 
Olivier et al., 2016). Three consecutive case ascertainment methods indicate a high 
prevalence among first graders in a Western Cape community (Table 1.2). 
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Table 1.2: Prevalence findings of FAS among different communities in South Africa. 
 
 
Although Cape Town is the most densely populated and major city in the Western Cape, 
about 40% of the population lives in the outer smaller towns and rural areas. The 
estimated population of the province is 3,721,200. Fifty-seven percent (57%) of the 
population are of mixed race (coloured), 18% black, 25% white and 1% other races 
(Viljoen et al., 2005). Alcohol use is highest in the province even among pregnant women, 
with over 20% of pregnant women drinking in a binge pattern (Viljoen et al., 2005). The 
high rate of alcohol use and FAS was found to be associated with some specific risk 
Study Setting Socioeconomic status 
(SES) 
FAS cases per 1000 
Active case 
ascertainment 
(May et al., 2009) 
Western Cape Coloured population 
(low and middle SES) 
White population 
(middle and upper SES) 
40.5 – 46.4 
Active case 
ascertainment 
(Viljoen et al., 2005) 
Western Cape Coloured population 
(low and middle SES) 
White population 
(middle and upper SES) 
65.4 – 74.2 
Active case 
ascertainment  
(May et al., 2007) 
 
Western Cape Coloured population 
(low and middle SES) 
White population 
(middle and upper SES) 
68.0 – 89.2 
Active case 
ascertainment  
(Urban et al., 2008) 
 
De Aar 
(Northern 
Cape) 
 
Upington 
(Northern 
Cape) 
Coloured/black 
(low and middle SES) 
 
 
Coloured/black 
(low and middle SES) 
111.4 
 
 
 
74.7 
Active case 
ascertainment 
(Rosenthal et al., 
2005) 
Gauteng Blacks                        
(middle and low SES) 
20 
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factors. These include poor socioeconomic status, poor maternal education, genetic and 
environmental factors (Urban et al., 2008). 
The Western Cape is a grape and wine producing area, contributing to the drinking 
pattern of its inhabitants. The dop system could be traced back to the colonial era in 17th 
century and has contributed siginificantly to high rate of alcohol use especially in the 
western cape. As such, the province has the highest prevalence of FAS in the world. It is 
a condition in which farm workers were provided with food or wine as part of their 
wages. Although is presently outlawed by different legislative bodies, minotrity of the 
farms are currently and actively practising the system (Viljoen et al., 2005).  
1.3.3 Growth retardation resulting from prenatal alcohol exposure 
Prenatal alcohol exposure results in growth deficiency, low body weight, short stature, 
and low weight to height ratio (O'Leary, 2004). Even in adulthood, osteoporosis and 
fractures are common among individuals that were exposed to alcohol prenatally. 
Research suggests that these effects may not be reversible despite adequate nutrition 
(Simpson et al., 2005).  
Rodent models of FAS show features such as low body weight, shorter bone length, 
delayed fetal skeletal ossification, and low skeletal maturity scores (Keiver et al., 1997; 
Keiver and Weinberg, 2004). These characteristics persist till weaning (3-week-old pups), 
however, possible effects at later stages have not been studied. Intrauterine alcohol 
exposure has also been shown to affect functional measures in bone health as seen in 
the study by Given and colleagues (2004), who reported that bone strength was altered 
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by maternal ethanol intake in fetal sheep. Studies suggest that low birth weight and 
impaired bone growth as well as a decrease in mineralisation in utero may reduce peak 
bone mass which increase the risk of osteoporosis later in life (Jones and Dwyer, 2000; 
Cooper et al., 2001; Godfrey et al., 2001).  
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1.4 BONE DEVELOPMENT 
To investigate how prenatal alcohol exposure affects the skeletal system, it in crucial to 
undertand how bone develops. Bone development comprises a series of complex 
processes which include cellular positioning and matrix deposition. This process of new 
bone formation is dependent on the biochemical environment. It is possible that 
prenatal elchohol exposre may alter the biochemical environment resulting in small, 
weaker bones at birth. Bone development (ossification) occurs by two distinct 
mechanisms: intramembranous bone ossification and endochondral bone ossification 
(Shapiro, 2008). 
1.4.1 Intramembranous bone ossification 
Intramembranous ossification is responsible for the formation of most of the craniofacial 
bones and the clavicle (Ortega et al., 2004). It occurs by initial rapid proliferation and 
differentiation of neural crest-derived mesenchymal cells to osteoblasts. This is then 
followed by mineralisation of the collagenous framework produced by the differentiating 
osteoblasts (Percival and Richtsmeier, 2013).  
1.4.2 Endochondral bone ossification 
Endochondral ossification is responsible for the formation of most of the vertebrate 
appendicular and axial skeleton. In this process, the mesenchymal cells differentiate into 
a cartilage model. This occurs at two different sites in developing long bone: the primary 
(diaphyseal) and secondary (epiphyseal) sites of ossification (Ortega et al., 2004).  
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Primary ossification 
Primary ossification involves the initial appearance of a cartilage model formed by 
condensation of mesenchymal cells (Fig. 1.1). Later, the cartilage is differentiated into 
chondrocytes that secrete extracellular matrix components. The cartilage model serves 
as a template for longitudinal growth in long bone formation. Once formed, the cartilage 
is invaded by differentiated osteoblasts at the center, forming a collar-shape primary 
center of ossification (Mackie et al., 2008). 
The cartilage enlarges in width and length, and is then subsequently invaded by new 
blood vessels (neovascularisation) within the primary bone collar leading to a transient 
stage of endochondral bone formation in the medullary canal and endosteal surface. 
Further growth of the diaphysis is achieved by direct appositional growth and restoration 
in the periosteal and endosteal surfaces respectively (Carter et al., 1996). Chondrocyte 
differentiation and neovascularisation are essential for smooth progression of 
endochondral ossification, this maintains normal fetal growth, as well as bone 
remodelling and repair in adult life (Stevens and Williams, 1999). 
Fully matured and differentiated osteoblasts are responsible for collagen (mainly type I) 
and alkaline phosphatase secretion. These are essential for extracellular matrix 
deposition and maturation. Moreover, non callagenous proteins (osteocalcin, 
osteopontin, osteonectin) are secreted by the osteoblasts. These proteins regulate 
maturation of the extracellular matrix. At the end of their lifespan, osteoblasts are found 
either lining the bone surface or trapped within the matured matrix, referred to as 
osteocytes (Eriksen, 2010). 
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Figure 1.1: Schematic representation of endochondral ossification. (A, B) Condensation of 
mesenchymal cells, differentiate into chondrocytes which produces the cartilaginous model of 
the bone. (C) Chondrocytes in the center of diaphysis undergo hypertrophy and apoptosis while 
they change and mineralise their extracellular matrix. Apoptosis of chondrocytes permits blood 
vessels to enter. (D, E) Blood vessels carry in osteoblasts, these bind to the degenerating 
cartilaginous matrix and deposit bone matrix. (F-H) Bone development and growth consist of 
proliferating, hypertrophic, and mineralising chondrocytes. Secondary ossification centers also 
form as blood vessels enter near the epiphysis of the bone. (Image adapted from Gilbert SF, 
2000). 
 
Secondary ossification 
In long bones, the epiphysis and metaphysis originate from an independent secondary 
ossification center. These two parts are separated from the diaphysis by segregation of 
differentiating chondrocytes collectively referred to as the growth plate. The growth 
Mesenchymal cells 
(A) (B) 
Cartilage model 
Hypertrophic 
chondrocytes 
(C) 
Osteoblasts (Bone 
formation) 
(D) 
Blood 
vessels 
(E) 
Proliferating 
Chondrocytes 
(F) 
(G) 
(H) 
Epiphyseal cartilage 
Bone 
Growth plate 
Growth 
plate 
Secondary ossification 
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plate is the main source of longitudinal growth in the developing long bone (Stevens and 
Williams, 1999). Irrespective of stage of development, the chondrocyte segregations 
(zones) and morphology are distinct (Fig. 1.2). Their distinction reflects changes in 
functional stages of the cells (reserve, proliferative and hypertrophic zones) (Mackie et 
al., 2008). 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Photomicrograph showing different chondrocytes morphology in different zones of 
the epphyseal growth plate (Image courtesy of Bello NK and Perry V).  
 
Reserve cell zone 
The layer furthest away from the ossification front is called the reserve cell zone. It is 
sometimes referred to as stem, germinal or resting cells zone (Fig 1.2). It is narrow, 
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consisting of single and paired irregularly arranged chondrocytes (Hunziker, 1994). In this 
zone, more of the extracellular matrix is deposited and the cells are dispersed and 
relatively quiescent (Ballock and O'keefe, 2003). The cells have many short filopodia 
extending from the plasmalemma to the surrounding matrix, giving them a scalloped 
appearance (Howlett, 1979). The reserve cell zone corresponds to the preparatory phase 
of rapid chondrocytes division, thereby contribituing to the longitudinal bone growth 
(Hunziker, 1994). 
At an early stage of development, the adjacent zone still consists of an epiphyseal plate 
called  the reserve zone cartilage. At maturity, the zone becomes embedded into the 
epiphyseal bone tissue (Hunziker, 1994). 
Proliferative zone 
The proliferating zone lies adjacent to the resting zone and the cells undergo rapid 
division (Fig 1.2). These cells appear granular coated which is believed to be from the 
product of the cells and discoid when viewed transversely. The cellular arrangement 
towards the pre-hypertrophic zone are disorganised and separated by a large amount of 
matrix (Howlett, 1979). This zone is crucial as it is possible that alcohol may impair cell 
division here and result in stunted growth.  
Hypertrophic zone 
In the hypertrophic zone, cellular division ceases and the cells begin to increase in size 
and are terminally differentiated (Fig 1.2). The size attained during hypertrophy is largely 
determined by the rate of proliferation. This terminal differentiation is associated with a 
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marked increase in alkaline phosphatase acitvity, synthesis and secretion of type-X 
collagen (Lui et al., 2011). The cells appear to have numerous matrix vesicles formed by 
budd6ing on the plasma membrane (Ballock and O'keefe, 2003). The cells eventually 
undergo apoptosis and of the transverse septa of cartilage matrix surrounding the cells 
break down. The vertical septa remain largely intact thereby allowing entry of the 
invading cells of ossification: osteoblasts precursor; osteoclasts; bone marrow cells as 
well as blood vessels (Ortega et al., 2004).  
1.4.3 Maintenance of bone structure 
Bone structrue and function is maintained during adulthood by the processes of 
remodelling and consolidation. Bone remodelling is a process of bone renewal to 
maintain its normal strength and homeostasis. Old and dead parts of the bone are 
replaced with newly synthesised and mineralised matrix (Clarke, 2008). The process 
follows sequential and regulated phases of resorption and formation that take place in 
what is termed Basic Multicellular Unit, which comprises osteoblasts, osteoclasts and 
osteocytes (Eriksen, 2010). 
The process of bone resorption is initiated by osteoclasts, which erode dead bone 
causing a lacuna called a resorption lacuna. The depth of the lacuna varies from 60µm in 
young adult to 40µm in the elderly. This is then followed by new bone formation by the 
osteoblasts (Eriksen, 2010).  
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1.5 BONE STRUCTURE AND FUNCTIONS 
In order to investigate the effects of gestational alcohol on the skeletal system, it is vital 
to undestand its structure and funcion. Bone is a specialised and complex tissue that 
performs two basic functions: mechanical and metabolic functions. Metabolically, bone 
is the major store or resevoir of calcium and phosphate (Weiner and Wagner, 1998). 
Mecha6nically, bone acts to protect the internal organs, load bearing, allows locomotion 
and houses the marrow stroma responsible for hematopoiesis (production of blood cells) 
(Boskey and Coleman, 2010). 
Four bone types exist; long, short, flat, and irregular bones. It is known that prenatal 
alcohol exposure results in stunted growth (Nwaogu, 2002; Simpson and Keiver, 2005; 
Snow and Keiver, 2007). Considering that long bones are important for height and 
growth, this study will pay attention to long bones. 
A long bone is composed of the diaphysis (shaft), epiphysis (larger upper and lower 
ends), and metaphyisis (an area between the diaphysis and epiphysis), which contains 
the growing cartilage (Fig. 1.3). Structurally, bone can be further classified into cortical 
(compact) and trabecular (cancellous) bone. The structures are better differentiated 
using histological evaluation (Rho et al., 1998). 
1.5.1 Cortical bone 
Cortical bone is a dense layer forming the outer wall of the diaphysis of long bone. It 
accounts for about 80% of the bone mass (Wehrli, 2007). The external surface of 
compact bone is covered by periosteum acting as a transition layer between the bone  
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Figure 1.3: General architecture of a long bone ( Right tibia). The metaphysis is an area between 
the diaphysis and epiphysis (Image courtesy of Bello NK and Perry V). 
 
and overlying tissues. Histologically the periosteum comprises of two layers: the outer 
fibrous layer and the inner cambium layer. The fibrous layer is composed of the 
superficial and the deep layer. The superficial layer is predominantly collagenous with 
few elastic fibers and is highly vascularised, contributing significant blood supply to the 
bone. The deeper layer is fibroelastic, less vascularised and recieves most of tendinous 
insertions (Dwek, 2010).  
The inner cambium layer lies in direct contact with the bony surface. It is highly cellular 
and comprises of adult mesenchymal progenator cells, fibroblasts and osteoblasts. These 
cells are important in periosteal bone formation and are a source of osteoprogenator 
cells (Allen et al., 2004). 
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Collagen fibrills, mainly type 1 collagen are the building blocks of compact bone. These 
collagen fibrils are secreted and arranged in an extracellular matrix interspersed by 
mineral crystals of calcium hydroxyapatite and water (Viguet-Carrin et al., 2006). They 
are arranged in a planner pattern called lamellae of 3 to 7µm wide (Fig. 1.4). They may 
also be arranged in a concentric layer surrounding a central canal, forming what is known 
as the osteon or Harvesian system. The osteon is about 200 to 500µm wide, running 
parallel to the long axis of bone (Rho et al., 1998) and connected together at a right angle 
by a canal called Volkmann’s canal. The Volkmann’s canal is lined internally by multiple 
layers of metabolically active osteoblasts and osteocytes during bone remodelling 
(Wehrli, 2007).   
 
 
Figure 1.4: Microarchitecural structure of compact bone showing the haversian system. Some 
parts of the outer layer of the periosteum enters the Volkmann’s cannal giving the thick 
anchoring collagen fibers called the Sharpy’s fibers  (Image adapted from Keirszanbaum and Tres, 
2012). 
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1.5.2 Trabecular bone  
Trabecular or cancellous bone is distributed within the medullary space of the cortical 
bone and epiphyseal end of long bone in higher quantity (Gibson, 1985). It is a network 
of cellular structures shaped into rods and plates. The rods and plates give the cells a 
characteristic open and closed shaped structures respectively (Fig 1.5). The cells in plate-
like parts are not completely closed, thereby allowing communication with the marrow 
stroma (Gibson, 1985). The rods and plates are attached in a three-dimensional 
arrangement. This connectivity is essential in maintaining sufficient tensile strength of 
bone (Dempster, 2000), and largely dependent on the connections of trabecular plates 
to struts (Hahn et al., 1992). 
 
 
Figure 1.5: Trabecular bone structure of the distal metaphysis of the hamster femur. The 
trabecular appears thick and continous  (Chen et al., 2001). 
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In human bone (iliac crest), specifically, the trabecular thickness ranges between 100 to 
500µm thick, and is lined internally by a layer of endosteal cells called osteoblasts with 
occasional multinucleatetd osteoclasts lining its margin. Externally, the whole structure 
is completely enclosed by a thin cortex making the bone spongy and lighter. The 
trabecular structure and its vasculature provides a larger surface area and vast substrate 
for cellular interaction. It also provides the basic frame work, nutritional supply and 
waste removal for effective haemopoiesis (Wilkins, 1992).  
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1.6 EFFECTS OF ALCOHOL ON BONE DEVELOPMENT 
1.6.1 Direct effects of alcohol on osteoblasts and on the growth plate 
Osteoblhasts are the principal cells in bone formation, and are directly affected by 
alcohol during bone formation. For example, in an in vitro environment, using human 
osteoblasts, alcohol caused a reduction in proliferation and osteoblasts number 
(Chavassieux et al., 1993). This reduction in osteoblasts number occured in a dose 
dependant manner (Friday and Howard, 1991), and may be as a result of overt toxicity 
or inhibition of intracellular cell proliferation signalling processes such as a reduction in 
polyamine levels. Polyamines (putriscine, spermidine, and spermine) are aliphatic 
amines that are implicated in cellular proliferation and division. It is possible that alcohol 
may affect their expression and function (Heby, 1981).  
Osteocalcin is expressed by osteoblasts and is thought to serve as a marker for 
osteoblastic function. Serum osteocalcin level  in human alcoholics has been found to be 
low, suggesting a secondary decrease in osteoblastic number and activity (Labib et al., 
1989). Lower serum osteocalcin level was also reported in alcohol exposed rats when 
compared to those on isocaloric controlled liquid diet. This was proposed to be as a result 
of alcohol effects on osteoblasts proliferation and activity (Peng et al., 1991). 
Apart from alcohol effects on the osteoblasts, alcohol can also directly affect morphology 
of the growth plate during early and late developmental stages. These changes involve a 
reduction in length of resting and hypertrophic zones as well as a shorter diaphysis. This 
leads to the subsequent reduction in fetal bone length. These effects on the resting and 
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hypertrophic zones suggests early and late damage of fetal bone development 
respectively (Snow and Keiver, 2007). 
Alcohol has adverse effects on the bone marrow, causing alteration in osteogenic 
differentiation, thereby promoting an increase in bone marrow fat content. This is 
suggestive of alcohol induced reduction in osteoblastic number and activity with 
subsequent reduction in bone formation (Gong and Wezeman, 2004). Another in vitro 
investigation showed that alcohol shifts the lineage committement of mesenchymal 
stem cells towards adipogenesis. This reults in deposition of more adipose tissue in the 
bone marrow stroma and subsequent osteopenia (reduction in bone mineral density) 
(Wezeman and Gong, 2004). 
1.6.2 Indirect effects of alcohol on growth and development 
Alcohol impairs calcium metabolism and homeostasis, indirectly affecting the role of 
calcium on bone growth and development. Calcium is an abundant nutrient in the body. 
Over 99% is stored in bone, while only 1% is found in the circulation in an ionised form 
(Ca2+). It is a crucial nutrient in bone formation, bone strength, and reduces osteoporosis 
fracture risk (Beto, 2015). Calcium homeostasis is also essential in maintaininag normal 
fetal growth and development. A study reported decreased fetal calcium levels as well 
as a decrease in physiological pH of fetal rats prenatally exposed to alcohol. 
Consequently, there was a reduction in fetal bone ossification with secondary reduction 
in fetal body weight and length (Keiver and Weinberg, 2004). In a similar study, a 
reduction in bone formation was observed in fetuses prenatally exposed to alcohol. This 
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reduction occurred through low calcium, calcium-regulating hormones and osteocalcinin 
fetal circulation (Keiver et al., 1996). 
Vitamin D, parathyroid hormone (PTH), and calcitonin, are crucial hormones in regulating 
and maintaining Ca2+ level in the circulation. In cases of low Ca2+ level, PTH stimulutes 
the productuon of Vitamin D and acts synergistically to cause bone resorption and 
subsequently increses Ca2+ in the circulation. Parathyroid hormone also decreses the 
rate of calcium loss via the urine  (Keiver et al., 1996). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
1.7 CELL DIVISION 
Cell division refers to a process by which cells produce two symmetrical or asymmetrical 
daughter cells (Roach et al., 1995). The latter, refers to the two daughter cells having a 
distinct fate due to differences in shapes, sizes, morphological or biochemical features 
(Horvitz and Herskowitz, 1992). Different cell type such as growth plate chondrocytes 
have been used to study the mechanisms of asymmetrical division (Jan and Jan, 1998).  
A study using male Long-Evans rats showed how chondrocytes in the proliferating zone 
of growth plate passes through different phases of division. The phases occur at a 
different rate over a single period of time (Wilsman et al., 1996), and in a regulated 
fashion called cell the cycle (Elledge, 1996). Generally, the cell cycle is composed of four 
stages of development: the gap before deoxyribonucleic acid (DNA) replication (G1), the 
phase of DNA synthesis or replication (S), the gap after DNA replication (G2), and the 
mitotic phase (M) during which cell division occurs (Table 1.3) (Hartwell and Weinert, 
1989). It is not clear whether gestational exposure affects or delays these phases of cell 
division. 
The mitotic stage comprises of four principal phases: prophase, metaphase, anaphase, 
and telophase. In prophase, chromosomal condensation and spindle is formed (King et 
al., 1994), this is followed by migration and alignment of the chromosomes to the 
opposite end (equatorial plane) of the cell in metaphase (Winey et al., 1995).   
In anaphase, two identical daughter chromosomes are produced from the cleavage of 
cohesion that binds the sister chromatid together. This is then followed by the final 
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stage, telophase, which is characterised by chromosomal uncoiling, development of two 
separate nuclei, and ultimate division of the cytoplasm to two daughter cells (FitzHarris, 
2012). 
 
Table 1.3: Phases of cell cycle 
State 
 
Phase Description 
Resting 
 
G0 The cell exit the cycle before commitment to DNA 
replication in subsequent cycle. It is a non-growing 
and non-replicating phase (Nurse, 1994). 
 
 
 
Interphase 
G1 
 
The cell in this stage prepare for DNA replication by 
increasing in size with intact control mechanism 
(check point) to ensure subsequent and effective 
DNA replication (Nurse, 1994). 
S 
 
 Phase of DNA replication (Nurse, 1994). 
G2 The cell continue to grow and prepare for the next 
mitotic stage (Schafer, 1998). 
Mitosis M 
 
Mitotic phase comprises of steps or pathways 
within the cell responsible for cell duplication and 
division (King et al., 1994). 
 
 
The cell cycle is controlled by complexes cyclin-dependent kinase (CDK) and cyclin 
(regulatory subunit). The two complexes are further regulated by three dependent 
mechanisms: abundant cyclin subunit, phosphorylation status of the CDK, and the 
presence of inhibitory proteins, cyclin dependent kinase inhibitors (LuValle and Beier, 
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2000). It is not clear whether alcohol acts in one of these stages and future research may 
shed light on these questions. 
  
 
 
 
30 
 
2 MATERIALS AND METHODS 
2.1 INTRODUCTION 
Animal studies are the basis of understanding the underlying mechanisms of alcohol’s 
teratogenicity. Human studies in this area are limited since pregnant women who drink 
alcohol may not volunteer for studies. Also, ethical considerations make it hard to use 
humans. For example, administration of alcohol to pregnant women is prohibited. 
Consequently, animal models are necessary to investigate the effects of gestational 
alcohol exposure on the developing embryo. 
The existing animal models include: rats, mice, guinea pigs, sheep, chick, zebrafish and 
non-human primates (Pattern et al., 2014). Due to their cost effectiveness, short 
gestation, ease of handling, high fertility and large litter size, rats are the most widely 
used animals in FAS research. Rats follow the same pattern of bone growth and 
development (endochondral ossification and periosteal bone formation) as humans. 
They also undergo the same age related bone loss as humans. However, it is crucial to 
acknowledge that rats are born at a stage of development that is prematurely relative to 
humans. With regards to osseous tissue development, a term rat is approximately 
equivalent to an early second trimester human fetus (Pattern et al., 2014). The 
development of long bones which is responsible for longitudinal growth occurs during 
the first trimester (Snow and Keiver, 2007). 
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2.2 STUDY SETTING 
2.2.1 Study animals 
The study was approved by the Animal Ethics Screening Committee (AESC), University of 
the Witwatersrand, Johannesburg (AESC 2015/27/15C) prior to commencement. Fifteen 
(15), three-months-old, virgin female Sprague-Dawley rats weighing an average of 300g 
were used. All the animals were sourced and housed at the Central Animal Services 
(CAS), University of the Witwatersrand. The animals were housed in transparent plastic 
cages lined with wood dust, with unlimited access to food and water. Room temperature 
was maintained at 23±2oC and a 12-hour light-dark cycle.  
2.2.2 Study design  
Allocation and treatment of animals 
Animals were randomly divided into three groups as follows; ethanol group, saline 
controls and untreated controls (Fig. 2.1). The ethanol group (n=6) received 0.015ml/kg 
body weight of 25.2% ethanol once daily for 19 days via oral gavage from the first day of 
gestation (Fig. 2.2).  This period covered the equivalent of first and second trimester in 
human during which most stages of bone development occur. The appearance of vaginal 
plug was considered day one of gestation. With respect to controls, the saline control 
group (n=6) received 0.015ml/kg body weight of 0.9% saline via the same route and for 
the same duration. The untreated control group (n=3) received neither alcohol nor 
saline. Fewer animals were used in the latter group to reduce the number of animals 
used in the study. 
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Figure 2.1: Conceptual study design. 
 
To monitor growth and general health, the dams were weighed daily at approximately 
10h00 using an electronic weighing scale (Snowrex Electronic Scale, Clover Scales, Pty, 
 Fifteen adult female Sprague-Dawley rats (Dams) 
                                       (N=15) 
  
             Time mated. Presence of vaginal plug indicated day one of gestation. 
Treated with 0.015ml per 
gram body weight                       
of 25.2% ethanol for 19 
days 
              n=6 
Treated with 0.015ml per 
gram body weight                        
of 0.9% saline for 19 days 
                n=6 
    
        
          No treatment 
              n=3  
 
Two pups from each dam were randomly selected and terminated by intraperitoneal 
injection of sodium pentobarbital on postnatal day 21 (n=30). 
                                                                                                                                                                                                                                                                                                                  
Bilateral tibiae (right and left) from each pup were 
harvested and cleaned off soft tissue, followed by fixation 
in 10% buffered formalin (n=60). 
 
The bilateral tibiae (right and left) harvested 
were subjected to three-dimensional micro-
focus computed tomography (µCT) 
investigations (n=60). 
The distal end of one tibia (left tibiae) 
from each pup was subjected to 
immunohistochemical analysis (n=30). 
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Model-WP OO3, Johannesburg). Daily food consumption was also measured. Food 
consumed was determined by subtracting the weight of the food remaining in the 
feeding trough from the weight of the food given the previous morning. To determine 
peak blood ethanol concentration, tail vein blood samples were collected weekly, an 
hour after oral gavage.  
 
 
 
 
 
 
 
 
 
Figure 2.2: process of oral gavage. The animal was held gently by grasping the loose skin on the 
back and the neck. A gavage needle was passed along the side of the mouth into the esophagus 
and towards the stomach. The solution was then gently passed directly in to the stomach (Image 
courtesy of R. Ndou).  
 
Birth and termination of pups 
The birth day of the pups in each litter was designated as day zero. The litter size was 
recorded upon birth and the pups were allowed to nurse freely with their dams for 21 days. 
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Upon reaching this age (21 days), two pups (n=30) from each of the dams (n=15) were 
randomly selected, weighed and crown rump length measured. The pups were then 
terminated by an intraperitoneal anesthetic injection of sodium pentobarbital. A 
thoraco-pelvic midline abdominal incision was made and slits were made on the skin 
covering the limbs to allow penetration of the fixative. Then the entire carcass was 
immediately immersed in freshly prepared 10% buffered formalin (Appendix 3) prior to 
dissection of the limbs.  
Tissue harvesting  
Bilateral hind limbs were carefully dissected and detached from the acetabulum using a 
pair of scissors, forceps and scalpel blade which were also used to excise all non-bony 
tissues. Knee joints were disarticulated and tibiae were removed, cleaned and 
subsequently immersed in fresh 10% buffered formalin for 24 to 72 hours prior µCT 
scanning (see section 2.8) and subsequent tissue processing for histological analysis (see 
section.2.5). 
Blood ethanol concentration analysis 
Tail vein blood (100 to 200µl) was collected into heparinised capillary tubes (Modulohm 
Vitrex®). Each capillary tube was sealed with prestick on both ends to retain the blood. 
Then paper towel was used to wrap the capillary tube before placing them individually 
into plastic bottles. These blood samples were immediately placed on ice. Within an hour 
after collection, all samples were stored at -80oC for preservation until analysis.  
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Microcapillary tubes were thawed to room temperature and spun in a microhaematocrit 
centrifuge (Haematokrit 210, SN 0031 386-04, Hettich, Germany) at 3000 rpm for 10 
minutes. Plasma alcohol concentration was carried out using the BioVision Ethanol 
Colorimetric Assay Kit (BioVision incorporation, Milpitas, USA) according to the 
manufacturer’s instructions. All reactions and readings were done in an alcohol-free 
environment using iMark Bio-rad Microplate Absorbance Reader (Bio-rad Laboratories 
Inc, USA, catalogue number 168-1130). The protocol followed is shown in appendix 4.  
The BioVision Ethanol Colorimetric Assay kit provides rapid, simple, and sensitive 
method for accurate quantification of ethanol concentration in various samples such as 
serum, plasma, food, beverages and other growth media. The ethanol is acted upon by 
alcohol oxidase to generate hydrogen peroxide (H2O2) that subsequently reacts with the 
kit’s probe to generate  colour 𝜆𝑚𝑎𝑥 = 570nm that was measured using a micro-plate 
reader. The kit detects alcohol levels of between 0.1 and 10mg/dl. 
2.2.3 Bone decalcification 
Left tibiae were rinsed in distilled water to remove excess formalin and then individually 
immersed in disodium ethylenedeamine tetraacetic acid (EDTA) approximately 20 times 
the bone volume for three weeks (Appendix 5). In the past, different solutions were used 
for decalcification which include: morse solution, 5% trichloroacetic acid, formic acid, 
and hydrochloric acid. These solutions were found to have negative effects on 
preservation of tissue morphology, antigenicity and DNA integrity. In contrast, EDTA is 
widely used in immunolocalisation because of its ability in tissue antigenicity 
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preservation. However, it requires a longer decalcification time taking several weeks or 
months (Castania et al., 2015). 
2.2.4 Test for end point decalcification 
To test for end point decalcification, 5ml of EDTA was withdrawn from under the 
specimen and placed in to a separate tube. About 10ml of ammonium oxalate was added 
to the same test tube. The mixture was left to stand overnight and then observed for 
presence of precipitate (Appendix 6). The absence of precipitate indicated complete 
decalcification of the respective bone. All bone samples were rinsed in slow running tap 
water for 30 minutes and then placed in fresh 10% buffered formalin for three weeks 
before subsequent processing.  
2.2.5 Bone length measurement 
Prior to processing, the length of the individual bones was measured using a Digital 
caliper (series 530). The use of digital caliper provides simple and accurate measurement 
of 0.01mm or even better. Bone tissue was placed in a flat surface and the two internal 
jaws of the caliper slightly touching the proximal and distal ends of the bone as the 
reference points. Each measurement was repeated until a consistent result was 
achieved. The value was then divided into three equal parts representing the length of 
the shaft, proximal and distal ends. The exact length of the distal end was measured and 
carefully separated from the shaft for subsequent processing and embedding. 
 
 
 
37 
 
2.3 TISSUE PROCESSING 
The distal end of the tibiae was then processed overnight in an automated tissue 
processor (Shandon Citadel 1000) as follows: fixation in 10% buffered formalin for 4 
hours, dehydration in 70% alcohol each for 1 hour, in 3 changes of 95% alcohol for 2 
hours each, in 3 changes of 100% alcohol for 2 hours each, in 2 changes of chloroform 
for 2 hours each and then impregnation in two changes of paraffin wax for 2 hours each 
(Appendix 7). 
2.3.1 Paraffin wax embedding 
Tissue samples were then embedded in paraffin wax making sure that the anterior 
surface of the distal end of the tibia was aligned in contact with the floor of the mold 
using forceps. The embedding wax, forceps and the molds were preheated at a 
temperature of 60oC. Tissue samples were positioned in the metal molds, filled with 
molten wax and then covered with well-labelled plastic cassettes. The wax blocks were 
then allowed to cool on a frosted surface for about 20 minutes (Appendix 8), before they 
were detached from the molds. 
2.3.2 Microtome serial sectioning 
Excess wax surrounding the block was trimmed using a blade. When trimming, care was 
taken to ascertain that the upper and lower horizontal edges were parallel to each other. 
The blocks were then trimmed to the level of the tissue with the microtome (miles 
scientific, serial number 31602-554). One corner was stripped off to keep the ribbon 
straight during sectioning and to recognise the leading end of the ribbon (Fig. 2.3).  
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The blocks were precooled on ice before cutting 5µm thick sections. A ribbon of 9 
sections was cut after discarding the first 20 sections. The ribbons of wax sections floated 
in a preheated water bath at 45oC to flatten tissue section 
 
 Surface of block wax facing 
                                                      microtome blade 
          Tissue embedded in wax 
  
 
(a) 
               Excess wax removed 
   Upper end trimmed off 
   Remaining wax holding the tissue 
 
 
(b)  
Figure 2.3: Trimming of wax blocks: (a) Shows the surface of wax block facing the microtome 
blade before trimming. (b) Excess wax removed and upper left corner trimmed off to 
determine the leading end of the ribbon.   
 
Once flattened in the water bath, the sections were separated with forceps. The 
individual sections where then mounted onto silane coated microscope glass slides in a 
sequential order (Fig. 2.4). 
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The first section was stained with hematoxylin and eosin (H&E), whereas every alternate 
second and third section was immunolabeled with the anti Ki-67 antibody and its 
negative control, respectively. This process was repeated after discarding the next 20 
sections resulting in each experiment done in duplicate.  
Slides were allowed to dry at room temperature and then stored in an oven at 37oC. The 
oven heated the slides and melted the wax surrounding the tissues and allowed the 
sections to further dry until when respective stain was conducted.  
 
   
(a) 
 
   
  
 
 
 
 
(b) 
Figure 2.4: Serial sectioning of tissue (a) Shows the manner in which ribbons were serially 
sectioned (b) Shows the way in which slides were labelled and sections were picked. 
    1 
   H&E 
  2 
   Ki-67 
 3 
    Neg 
  4 
     H&E 
 
5 
    Ki-67 
 6 
     Neg 
   7 
     H&E 
 8 
   Ki-67 
 9 
   Neg 
      H&E            
 
       Ki-67     Negative 
1 2 3 
4 5 6 
7 8 9 
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The use of silane coated slides allowed an increased adhesive property of the tissue 
sections to the slides. The microscope slides were coated as follows: slides were arranged 
in a rack and completely immersed in 2% 3-aminopropyltriexothysilane (APES) for 30 
minutes, rinsed in 2 changes of acetone for 10 dips, rinsed in 2 changes of distilled water 
for 10 dips, and then air dried at a 450 angle. Slides were then incubated in an incubator 
(model 508-2U, Labcon shaker) overnight at 370 (Appendix 9). 
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2.4 STAINING OF TISSUE SECTIONS  
2.4.1 Haematoxylin and eosin staining 
The haematoxylin and eosin stain is used to determine the architectural organization of 
tissue. Haematoxylin has the ability to stain the nuclei blue/black, while the eosin gives 
cytoplasm and connective tissue a pinkish and red colours respectively. This 
differentiates between the nuclear and non-nuclear components of the cell. In brief, 
sections were initially dewaxed in xylene for 2x 10 minutes and rehydrated by passing 
them through series of decreasing alcohol concentration (100%, 95%, and 70%) for 3 
minutes each, and eventually rinsed in distilled water for 5 minutes. The sections were 
then stained with haematoxylin for 10 minutes, washed in running tap water for 2 
minutes, differentiated in periodic acid for 2 dips, rinsed in slow running tap water for 2 
minutes, blued in Scott’s tap water for 2 minutes and then rinsed again in tap water for 
10 minutes. Sections were stained with eosin for 2 minutes for cytoplasm staining and 
then dehydrated with increasing concentration of ethanol (70%, 95%, and 100%) for 3 
minutes each, cleared in 2 changes of xylene for 10 minutes each and finally mounted in 
entellen (Appendix 10.1). 
Use of Scott’s tap water as a bluing agent has been found to be associated with gentle 
and smooth bluing of haematoxylin and decrease loss of tissue sections. The water was 
prepared by dissolving 2g of sodium hydrogen carbonate and 10g of magnesium sulphate 
in one litter of distilled water. The solutions were then stored in room temperature 
(Appendix 10.2). 
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2.4.2 Detection of cellular proliferation 
Cellular proliferation remains an important tool in the study of many physiological and 
pathological processess. Biological methods have been used to explain various activities 
involved in different phases of cell cycle or proliferation. These methods can be broadly 
classified under DNA content analysis and immunohistochmeical methods (Hall and 
Levison, 1990). 
2.4.2.1 DNA content analysis 
DNA synthesis occurs during the S phase of the cell cycle and relies on incorporation of 
the precursors mainly pyrimidine deoxynucleoside to form the daugter DNA. Chemical 
staining of these precursors can be achieved, thereby assessing the rate of DNA 
replication. These methods include: thymidine labelling (incorporation) and tetrazolium-
based colorimetric assay (Salic and Mitchison, 2008). 
2.4.2.2 Immunohistochemical methods 
Bromodeoxyuridine incorporation 
Bromodeoxyuridine  is a synthetic analogue of thymidine commonly used to detect DNA 
synthesis during the S phase of cell cycle (Hall and Levison, 1990). Bromodeoxyuridine is 
incorporated into the replicating DNA in the place of thymidine (5-iodo-2’-deoxyuridine). 
Anti BrdU antibodies can subsequently be used, thereby detecting an actively replicating 
DNA (Konishi et al., 2011).  
Althogh the technique is widely used for detection of cellular proliferation, it is time 
consuming, expensive and radioactive making it not suitable for tissue incubation (Yu et 
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al., 1992). Moreover, tissues needs to be subjected to strong denaturation using 
concentrated hydrochloric acid or mixture of methanol and acetic acid. This may cause 
tissue destruction and decrease the intensity of bromodeoxyuridine (Salic and Mitchison, 
2008). 
Anti-Ki-67 antibody 
Ki-67 is a nuclear antigen (Brown and Gatter, 1990) that is expressed by the proliferating 
cells during all the phases of cell cycle except the G0  phase (Gerdes et al., 1984). The 
expression increases during the later half of S phase reaching its maximum at G2 and M 
phases of the cycle (Sasaki et al., 1987; Landberg et al., 1990; Bruno and Darzynkiewicz, 
1992).  
Previous studies show the anti Ki-67 antibody to have been used in detecting cellular 
proliferation in neoplastic and non neoplastic conditions; lymphoproliferative diseases, 
CNS tumours, connective tissue tumours and breast disease (Brown and Gatter, 1990). 
Likewise, the antibody was used to detect the presence of Ki-67 antigen secreted by 
various tissue components of the growing human long bones (Apte, 1990). Detection of 
the Ki-67 antigen is found to be most effective on frozencryostat sections. Thus, a heat 
induced atigen retreval step is therefore needed to effectively expose the epitope from 
protein complexes formed in formalin fixed tissue (McCormick et al., 2002). The use of 
anti Ki-67 antibody is a widely accepted immunohistochemical method of detecting 
cellular proliferation for the following reasons: 
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1. It is a direct, rapid and cost effective method of determining cellular proliferation 
(Hitchcock, 1991). 
2. Ki-67 antigen is expressed specifically by actively proliferating cells. Therefore, the 
antibody plays a central role for detecting cellular proliferation (Brown and Gatter, 
1990). Its usefullness as a tumour marker has to be tested for each tomour type 
and usage (Scholzen and Gerdes, 2000). 
3. Ki-67 antibody is easily catalysed having a shorter half-life, thereby making it a 
strongly accepted marker of proliferation when compared to general markers 
(Bruno and Darzynkiewicz, 1992). 
2.4.3 Immunohistochemistry 
Chondrocytes proliferation is crucial in bone development. The anti-Ki-67 antibody 
(ab6246212 abcam) has received much larger attention as a marker for cellular 
proliferation. The antibody was found to be reactive with a nuclear structure present 
only in proliferating cells. The procedure was carried out over three days using the Rabbit 
Specific HPR/DAB (ABC) detection IHC kit (ab624621 abcam) as per manufacturer’s 
instructions. The first day of the procedure involved dewaxing (2x 5 minutes) and 
rehydrating the tissue sections, washing tissue sections in running tap water for 5 
minutes. The slides were then immersed in staining rack filled with citrate buffer solution 
(pH=6) and allowed to stay overnight in water bath (model number 416, serial number 
SE 9455) set at temperature of 600C. The high temperature and calcium chelating by 
citrate destroys the protein complex formation in formalin fixed tissue thereby 
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unmasking the specific epitopes within the protein molecules for effective antigen-
antibody reaction (Shi et al., 2001). 
The second day, tissue sections were allowed to cool to room temperature for 20 
minutes and then washed in phosphate buffer solution (PBS) (pH=7.4) for 5 minutes. 
Endogenous peroxidase was blocked with 1% hydrogen peroxide (H2O2), washed with 
PBS for 3x 5 minutes, incubated with normal goat serum for 10 minutes, incubated with 
primary antibody (ki-67 in 1:1200 dilution factor) overnight at 40C. Endogenous 
peroxidase is an enzyme (produced by most tissues) that can produce nonspecific 
staining background. Although the enzyme activity is known to be destroyed during 
fixation, treatment of tissue section with 1% H2O2 will further reduce or completely 
abolish the nonspecific staining background (Ramos-Vara, 2005). 
The third day, sections were allowed to reach room temperature, washed in PBS for 3x 
5 minutes, incubated with biotinylated secondary antibody, washed in PBS for 3x 5 
minutes, incubated with strep avidin HRP, washed in PBS for 3x 5 minutes. Sections were 
then incubated with DAB (3-3’ di-amino benzidine) working solution for 5 minutes, rinsed 
in running tap water for 5 minutes, hydrated through graded alcohol, cleared in xylene 
and eventually mounted in entellen (Appendix 10.3). 
Use of strep avidin in immunohistochemical staining has been shown to inhibit the action 
of biotin. Biotin is widely produced by many tissues including bones and can produce 
nonspecific staining background. It can also bind to the antibodies or the enzyme 
epitopes used in detecting target antigen. Strep avidin has high affinity to the biotin 
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thereby inhibiting the interaction and abolishing the nonspecific staining background 
(Ramos-Vara, 2005). 
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2.5 IMAGING MODALITIES 
Different imaging mordalities for the assessment of skeletal morphology and 
microstructure exist. These include: plannar radiography, peripheral dual-energy X-ray 
absorptiometry, peripheral quantitative computed tomography, magnetic resonance 
imaging, synchrontron radiation and µCT (Christiansen and Bouxsein, 2013). The latter 
has become the goal standard imaging technique in assessment of bone 
microarchitecture (Bouxsein et al., 2010). 
2.5.1 Peripheral dual x-ray absorptiometry 
Peripheral dual x-ray absorptiometry (pDXA) involves exposing the specimen to two 
sources of energy beams: low and high energy beams. The ratio of the two energy 
beam’s attenuation allows the separation of bone from soft tissue and fat (Christiansen 
and Bouxsein, 2013). Measurements of body composition and skeletal structure using 
pDXA is associated with some limitations which include: poor accuracy, underestimation 
of lean tissue mass and overestimation of fat mass (Nagy and Clair, 2000; Brommage, 
2003). Despite efforts by few investigators to standardise the measurements, the 
technique is generally associated with limited spatial resolution, assessment of areal 
two-dimensional bone marrow density rather than volumetric and an inability to 
delineate between trabecular and cortical bone compartments (Christiansen and 
Bouxsein, 2013). 
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2.5.2 Magnetic resonance imaging 
Magnetic resonance imaging is widely used to assess bone microstructure based on the 
strong magnetic fields. It is a non-invasive and nonionizing technique (Genant and Jiang, 
2006). Bone tissue gives a weak micro resonance signal due to lack of protons, whereas 
soft tissues produces strong micro resonance signals due to the presence of protons. This 
contrast allows easy delineation and quantification of trabecular bone structure (Jiang 
et al., 2000; Christiansen and Bouxsein, 2013). Certain limitations affect in vivo detection 
of trabecular bone in smaller animals (Jiang et al., 2000). These limitations include: 
spatial resolution, total imaging time and limitations of signal-to noise. However, images 
can show network of larger trabeculae (Genant and Jiang, 2006). 
2.5.3 Microcomputed tomography 
Microcomputed tomography (µCT) was developed by Feldkamp and colleagues in late 
80’s and  is recently the gold standard technique in assessing the microarchitecture of 
bone. The resolution allows clear visualisation of individual smaller trabeculae. When 
using µCT, it is easy to directly quantify the trabecular structure such as trabecular 
volume, number, thickness, and separations (Genant and Jiang, 2006; Bouxsein et al., 
2010).  
Studies have shown that µCT is relatavely more accurate in assessing trabecular bone 
strucuture compared with other imaging modalities (Kapadia et al., 1998; Barbier et al., 
1999; Waarsing et al., 2004; Bonnet et al., 2009). However, a study reported an 
overestimate of the trabecular measuremets (trabecular bone volume, trabecular 
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thickness and separation) relative to histomorphometric analysis. This may be attributed 
to the choice of inadequate resolution relative to trabecular size and poor threshold 
selection. Moreover, measurements on trabecular nodes tend to increase trabecular 
thickness compared to the measurement on trabecular struts (Chappard et al., 2005).  
Advantages of using Micro Computed tomography   
Despite above mentioned limitations of using µCT, it has several advantages making it 
suitable over other imaging modalities: 
1. It allows direct three-dimensional measurement of trabecular number, 
thickness, and separations rather than assumption based on two-dimensional 
stereological method (Hildebrand and Rüegsegger, 1997). 
2. It is fast, precise and non-destructive. The specimen can be used subsequently 
for further assay (Rüegsegger et al., 1996). 
3. Much larger volume of interest can be analysed (Bouxsein et al., 2010). 
4. By comparing material attenuation to that of known, µCT can provide an 
estimate of bone tissue mineralisation (Fajardo et al., 2009). 
2.5.4 Light microscopy and photomicrography 
Photomicrographs of the stained slides were taken under light microscope (Zeiss 
Axioscope 2 plus) fitted with an axiocam HRC digital camera (identification number 105-
041756). Photomicrographs of the medial, lateral and central region of each section were 
taken under ×10 magnification for assessment of chondrocyte number, cellular 
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proliferation and areas of the different chondrocytes zones (proliferative and 
hypertrophic) of the distal growth plates. 
Photomicrographs were imported into Fiji Image-J software and the parameters 
measured were delineated based on cell morphology. The proliferative zone is limited 
by the first flattened chondrocyte on the bottom side and the first hypertrophic 
chondrocytes on the upper side. Whilst the hypertrophic zone is limited by the first 
hypertrophic chondrocytes from the bottom side and by the last transverse septum on 
the upper side (Fig. 2.5). Absolute parameters assessed include the following: cell count, 
cellular area, growth plate area, as well as cellular proliferation. 
 Cell count 
Cell count was determined as the average number of cells within each zone of the growth 
plate (proliferative and hypertrophic zone) as follows: images were converted to 
greyscale (8-bit) after which the area of the cells to be counted were highlighted. This 
was done using the “set” button in image-J to type in a known pixel intensity thereby 
creating a binary version of the image with two pixel intensities: black = 0 and white = 
255. For merged cells, process > binary > watershed, and fill holes was used to accurately 
separate them by adding one-pixel cell line and fill holes respectively. The menu 
command (process > binary > watershed) convert the image to binary by thresholding. 
The black pixels are then replace with a grey pixels with black pixels closer to the edge 
lighter than the black pixels that are more central. This is the Euclidian distance map of 
the black area from which the centre of the particles are calculated. They are the 
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ultimate eroded area of each black area which is equivalent from each area, the points 
are then dilated until they touch another black pixel. The meeting point is where a 
watershed line is drawn. The region of interest (ROI) was selected and particles were 
analysed. To count all the particles, the Image J setting was adjusted to the default of 0-
infinity. Finally, clicking an outline option shows a copy of the image and all counted 
particles as well as the cellular area were shown in numbered outlines (Appendix 11). 
 
 
Figure 2.5: Photomicrograph of the growth plate (distal end) showing the proliferative and 
hypertrophic zones. Proliferative zone (PZ) and hypertrophic zone (HZ) areas (irregular lines) 
are delineated. Haematoxylin and eosin (Image courtesy of Bello NK and Perry V). 
 
Cellular area 
Cellular area was determined as the average sum of the areas occupied by the cells in 
each zone (proliferative and hypertrophic zone) as explained above.   
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Growth plate area 
Growth plate area was determined as the average sum of the resting, proliferative and 
hypertrophic zones areas. Following the automated routine threshold setting as 
explained above, the entire growth plate area was selected using a polygonal selection 
tool. An outline of the analysed area was drawn. 
Cellular proliferation 
Cellular proliferation was determined as the average number of Ki-67 positive cells 
within the proliferative and hypertrophic zones of the growth plate as described above. 
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2.5.5 Three-dimensional micro-focus x-ray computed tomography  
Recently, high-resolution three dimensional (3D) imaging technique has received much 
attention in evaluating bone morphology and microarchitecture. It involves the use of X-
ray attenuated data that is acquired at multiple viewing angles to reconstruct a 3D 
representation of the specimen. The accuracy and non-destructive advantages of 
assessing bone morphometry by µCT makes the specimen useful for other subsequent 
assays (Bouxsein et al., 2010). 
Microfocus computed tomography x-ray machine (NIKON XTH 225/320 LC) was used in 
this study. The samples preserved in 10% buffered formalin were first freed of excess 
fluid by patting around the bone with a paper towel prior to scanning. The bones where 
then individually wrapped in Styrofoam and placed in a plastic container. Wrapping 
Styrofoam around the bone ensured that the sample remained stationary during 
scanning while allowing the X-rays to get to the sample with negligible absorption. The 
plastic container with the sample inside was then positioned on a rotating manipulator 
in the scanning chamber for the scanning. The scanning parameters used are shown in 
table 2.1. 
Parts of the tibia studied 
The full bone length was measured using the VG studio built in calliper. Cross-sectional 
area, cortical area and medullary canal area of the shaft were measured at two positions, 
50th (midshaft) and 75th (distal) percentile marks of the tibial length (Fig. 2.6). These 
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points were determined by dividing the bone length into quartiles. From the midshaft, 
the circumference was also taken.  
 
Table 2.1: Scanning parameters 
Parameter Value 
X-ray voltage                                                                    70kv 
X-ray current                                                                    400µa 
Filter                                                                                     1mm aluminium 
Scanning resolution                                                      15µm 
Tomographic rotation                                                  360 degrees 
Rotation step                                                                    1 degree 
Frame averaging                                                              4
Scan duration                                                                   8 minutes 
 
 
 
Figure 2.6: Three-dimensional reconstruction of the tibia showing the parts that were 
investigated. (a), full tibial length; (b), 75th percentile mark; (c), 50th percentile mark (midshaft). 
The blue part represents the distal epiphysis in which trabecular morphometrics were studied. 
The yellow part is the shaft (Image courtesy of R. Ndou). 
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Table 2.2: Trabecular parameters assessed 
 
Parameters                                   Abbreviation                               Definition 
 
Bone volume to total volume    BV/TV                        Represents the ratio of material (bone)   
                                                                                             to total volume.    
                               
Mean trabecular thickness        TbTh                             Specifies the mean thickness of                                                                            
                                                                                              trabecular (column-like) structures in  
                                                                                              the material (bone), calculated as   
                                                                                              follows: TbTh = (2/BS)/BV 
                                                                                                                                                                                                                   
                                                                                              Where BS/BV is the ratio of material 
                                                                                              (bone) surface (BS) to material (bone)  
                                                                                              volume (BV). 
Trabecular number                       TbN                             Shows the mean number of trabecular  
                                                                                              (column- like) structures per unit length,  
                                                                                              calculated as follows: TbN(BV/TTTbTh 
 
Mean trabecular spacing            TbSp                             Indicates the mean distance between  
                                                                                              Trabecular (column-like) structures, 
                                                                                              calculated as follows:  
                                                                                              TbSp = 1/TbN − TbTh 
 
 
 
Bone morphometry 
Reconstruction was done using 3D Pro® after which, VG studio Max® 3.0 was used for 
data analysis. The gray values representing the container were excluded using the import 
histogram. On the preview, the parts representing air were also cut out to reduce 
computer memory processing power required during analysis. Care was taken to ensure 
the sample was not cut out. To ensure that only the bone material was being examined, 
manual surface determination was applied ascertaining that the background was 
removed without compromising the sample material of interest. The region of interest 
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was then selected for surface determination. After selecting the distal epiphysis as a 
region of interest, the trabecular number, thickness, spaces and volume were obtained 
under “morphometrics” on VG studio. 
Osteometric measurements were obtained using the built-in caliper. The full bone length 
was divided to determine the midshaft and further divided into four to determine the 
quartile marks. A cross sectional slice from each quartile was then saved for further 
analysis on Fiji image J. From these slices, cross sectional circumference, cross sectional 
area and cortical thickness where obtained as described in appendix 12. Cortical 
thickness was the difference between the cross-sectional area and the medullary cavity 
area.  
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2.6 STATISTICS ANALYSIS 
The data were managed in Microsoft Excel 2016 (Microsoft Corporation) and analysed 
using SPSS® version 24, IBM®, 2017. The Shapiro Wilks test was used to test for normality. 
Since the data were parametric, ANOVA with LSD post-hoc was used to test for group 
differences. Pearson’s correlation was used to test for relationships between 
parameters. Binary logistic regression was used to predict group membership into either 
the ethanol or saline control group. The data are reported as mean ± standard deviation. 
Significance level was set at p < 0.05. 
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3 RESULTS 
3.1 Measurement reliability 
Lin’s concordance correlation coefficient for intra and inter observer errors showed pc 
values above 0.7 for all measurements. Values for pc range from -1 to 1 and a value close 
to 1 indicates a high degree of measurement similarity. Greater than 0.7 pc values 
obtained herein indicate that the correlation between repeated measurements was high 
and thus measurement error was minimal. 
3.2 Blood alcohol concentration 
The mean blood ethanol concentration was 258.77mg/dL in the ethanol group and 
81.53mg/dL in the saline controls. The untreated controls were not tested for blood 
ethanol concentration as they did not receive treatment. 
3.3 Food consumed and weight gained during the gestation period 
All three groups studied showed similar daily food consumption in each week. The food 
intake was highest in week 3 for all the groups, and was not significantly different 
between the groups (p=0.75 for ethanol vs saline control) (Fig. 3.1). With respect to the 
weight gained per week, the ethanol group showed a negligible gain from week 1 (28.3g) 
to week 2 (29.42g). In contrast, the saline and untreated controls exhibited a slight 
weight decrease from week 1 to week 2 (34.21g – 29.21g and 30.5g – 24.83g 
respectively). However, all the three groups showed a major weight increase from week 
2 to week 3 (Fig. 3.2). The ethanol group had the least total weight gained for the entire 
gestation period (Fig. 3.3). 
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3.4 Gestation duration and litter size  
The gestation duration ranged from 19 to 24 days (Table 3.1). This range was 21-24 days 
in the ethanol group and 19-23 days in the saline controls. The untreated controls had 
23 days gestation. However, there were no statistical group differences in gestation 
duration (p=0.37 for ethanol vs saline control). There was a wide range of litter size 
among the three groups, with the smallest being 3 in the ethanol group and the largest 
observed in the untreated controls that had a maximum of 17 (Table 3.1). This group also 
had the smallest range of 14 -17. This contrasts with the ethanol group (litter size 3-16) 
and the saline controls (litter size 5-16). However, no significant differences were 
observed between the groups (p=0.28 for ethanol vs saline control). Each of the three 
groups in the study had 2 pups found dead at birth. 
 
 
 
 
 
 
 
 
Figure 3.1: Food consumption. The daily food consumption in grams is shown as an average per 
week for all three groups in the study. Error bars represent standard deviation. 
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Figure 3.2: Weight gain. The weekly mean weight gained in grams is shown for all three groups 
in the study. Error bars represent standard deviation. 
 
 
 
 
 
 
 
 
Figure 3.3: Overall weight gain. The total mean weight gained in grams for the entire gestation 
period is shown for all three groups in the study. Error bars represent standard deviation.                                                          
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Table 3.1: Gestation duration and litter size for the ethanol group, saline and untreated 
controls. The number of dead pups (n = 2) in each group is included in litter size. 
 
 
3.5 Pups weights and crown rump length at 3 weeks of age 
Minor differences in the weight of the pups at the age of 3 weeks were observed. The 
ethanol group (47.41g) weighed marginally lower than the saline (48.20g) and untreated 
controls (50.83g) (Fig. 3.4). These differences were not statistically significant (p=0.45). 
The crown rump length was similar in the ethanol group and the saline controls (9.70cm), 
being significantly higher in the untreated control group (p=0.01 for untreated control 
against the ethanol and saline groups) (Fig. 3.5). 
 
 
 
 
 
Group N Minimum Maximum Mean SD 
Ethanol 
Gestation 6 21 24 23.00 1.095 
Litter size 6 3 16 9.83 4.916 
 
      
Saline Control 
Gestation 6 19 23 22.00 1.732 
Litter size 6 5 16 12.14 3.671 
 
      
Untreated Control 
Gestation 3 23 23 23.00 0.000 
Litter size 3 14 17 15.33 1.528 
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Figure 3.4: Weight of the pups at 3 weeks of age. The mean weight is given in grams for all three 
groups in the study. Error bars represent standard deviation.  
 
                                                                                                          
 
 
 
 
 
Figure 3.5: The crown rump length of the pups at 3 weeks of age. The values are means in grams 
for all three groups in the study. Error bars represent standard deviation. A line connects group 
with significance difference from the ethanol group. 
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3.6 Histomorphometry and immunohistochemistry for Ki-67 protein 
Growth plate surface area 
The growth plate surface area was smallest in the ethanol group (Mean=7.87mm2 ±2.05) 
compared to the saline and untreated controls (Mean=9.09 mm2 ±1.11 and 9.24 mm2 
±1.05, respectively). However, no significant differences were observed among all three 
groups (p=0.05) (Fig. 3.6a). 
Proliferative zone  
The ethanol group exhibited fewer cells (Mean=1637.00 ±356.60) than the saline and 
untreated controls (Mean= 1808.56 ±742.88 and 2435.67±638.94, respectively). These 
cells were significantly fewer between the ethanol and the untreated group (p=0.03) (Fig. 
3.6b). The ethanol group also had the smallest (Mean= 0.18 mm2 ±0.06) proliferative 
zone surface area compared to the saline (Mean= 0.28 mm2 ±0.18) and untreated 
controls (Mean= 0.27 mm2 ±0.11). However, no significance differences were observed 
(p=0.05 for all group comparisons) (Fig. 3.6c). Similarly, fewer Ki-67 labelled cells were 
found in the ethanol group (Mean=1038.13 ±213.79) than the saline controls 
(Mean=1568.00 ±302.92) and untreated group (Mean=1484.75 ±200.65) (p=0.001 and 
0.003, respectively) (Fig. 3.6d). 
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Figure 3.6: Histomorphometry and Ki-67 positive cells in the tibial distal epiphyseal plate. (a) 
epiphyseal surface area, (b) proliferative zone number of cells (c), proliferative zone surface area 
and (d) the number of Ki-67 positive cells in the proliferative zone are given for the ethanol, saline 
control and untreated control groups. Error bars represent standard deviation and a line 
connects bars with significant difference from the ethanol group. 
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Hypertrophic zone  
In the hypertrophic zone, the ethanol group had fewer cells (Mean=1199.71 ±120.93) 
than the saline controls (Mean=1421.50 ±431.27) and the untreated group 
(Mean=1459.42 mm2 ±146.34). However, no significant differences were observed 
(p>0.05 for all group comparisons) (Fig. 3.7a). The ethanol group also had the smallest 
(Mean=0.14mm2 ±0.06) hypertrophic zone surface area compared to the saline 
(Mean=0.17 mm2 ±0.05) and untreated controls (Mean=0.18 mm2 ±0.02). However, no 
significant difference were observed from each other (p=0.05) (Fig. 3.7b). Similarly, 
fewer Ki-67 labelled cells were found in the ethanol group with significant differences 
observed only between the ethanol (Mean=1081.19 ±207.14) and the saline group 
(Mean=1157.25 ±232.37) (p=0.003) (Fig. 3.7c). 
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Figure 3.7: Histomorphometry and Ki-67 positive cells in the tibial distal epiphyseal plate 
hypertrophic zone. (a) hypertrophic zone number of cells, (b) hypertrophic zone surface area 
and (c) the number of Ki-67 positive cells in the hypertrophic zone are given for the ethanol, 
saline control and untreated control groups. Error bars represent standard deviation and a line 
connects group with significance difference from the ethanol group 
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3.7 Osteometry  
The mean full bone length was similar in all three groups studied (ethanol, 
mean=21.08mm ±0.95; saline control, mean=21.23mm ±1.38 and untreated control, 
mean=21.88mm ±0.94) (Fig. 3.8a). This similarity among the groups was also observed 
in the shaft length. The mean shaft length for the ethanol group was 17.77mm ±0.92 and 
17.51mm ±1.32 for the saline and untreated controls a mean of 18.22mm ±0.74 (Fig. 
3.8b). In contrast, the distal volume showed differences between the study groups, with 
the ethanol group showing a significantly smaller volume (Mean=3.51mm3 ±1.07) than 
the saline (Mean=4.35 mm3 ±0.78) and untreated controls (Mean=4.26 mm3 ±1.02) 
(p=0.007 and p=0.04 for the ethanol group compared to the saline and untreated groups 
respectively) (Fig. 3.8c).  
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Figure: 3.8: Measurements and volume: (a) full bone length, (b) shaft length and (c) distal 
volume. All parameters are given for the ethanol, saline controls and untreated controls. Error 
bars represent standard deviation.    
 
3.7.1 Trabecular parameters 
The ethanol group (Mean=54.73% ±14.53) also had less bone to total volume (BT/TV) 
compared to the saline (Mean=66.81% ±11.05) and untreated controls (Mean=68.83% 
±15.35) (Fig. 3.9a). This difference was significant for the ethanol and saline groups 
(p<0.001) with both control groups showing similarity (p=0.38). The ethanol group 
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(Mean= 0.14 ±0.10) showed the thinnest trabeculae (TbTh) of all three groups in the 
study, being significantly lower than the saline control (Mean= 0.20 ±0.08) (p=0.03) (Fig. 
3.9b). The number of trabecular (TbN) was similar in all three groups (ethanol, 
mean=5.04 ±1.70; saline control mean=5.46 ±1.32 and untreated control mean=5.48 
±0.61) (Fig. 3.9c). However, differences in trabeculae spacing (TbSp) occurred, with the 
ethanol group (Mean=0.08mm ±0.04) displaying less spacing than the saline 
(Mean=0.13mm ±0.06) and untreated group (Mean=0.13mm ±0.06) (Fig. 3.9d). These 
differences were statistically significant for both the ethanol and untreated controls 
(p=0.002 and p=0.02 for the ethanol group compared to the saline and untreated groups 
respectively.   
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Figure 3.9: Trabecular morphometric parameters (a) bone volume to total volume (BV/TV), (b) 
trabecular thickness (TbTh), (c) trabecular number (TbN), (c) trabecular spacing (TbSp). All 
parameters are given for the ethanol, saline controls and untreated controls. Error bars 
represent standard deviation and a line connects group with significance difference from the 
ethanol group. 
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3.7.2 Midshaft cross-sectional area, cortical area (thickness) and medullary canal area  
The midshaft cross sectional area was similar in all three groups studied. The ethanol 
group had mean of 2.48 mm2 ±0.41 and the saline and untreated groups had 2.51 mm2 
±0.37 and 2.45 mm2 ±0.44, respectively (Fig. 3.10). The medullary canal area was greater 
in the ethanol group (1.01 mm2 ±0.25) in comparison to the saline and untreated controls 
(Mean=0.96 mm2 ±0.16 and 0.862 mm2 ±0.12 respectively). Significant differences in 
medullary canal area where observed between the ethanol and untreated controls 
(p=0.05) (Fig. 3.11). Regarding cortical area (thickness) in this bone region, the ethanol 
group (Mean=1.47 mm2 ±0.32) exhibited a marginally lower value compared to the saline 
and untreated controls which had the same size area (Mean=1.5 mm2 ±0.25 and ±0.45, 
respectively) (Fig. 3.12).   
 
 
Figure 3.10: Midshaft cross-sectional area. The mean cortical area at the 50th percentile mark is 
given for the three groups studied. Error bars represent standard deviation. 
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Figure 3.11: Midshaft medullary canal area. The mean medullary canal area at the 50th 
percentile mark is given for the three groups studied. Error bars represent standard deviation.    
 
 
 
Figure 3.12: Midshaft cortical area. The mean medullary canal area at the 50th percentile mark 
is given for the three groups studied. Error bars represent standard deviation. 
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3.7.3 Distal cross-sectional area, cortical area (thickness) and medullary canal area  
The distal cross-sectional area was marginally lower in the ethanol group (Mean=3.14 
mm2 ±0.56) compared to the saline and untreated controls (Mean=3.38 mm2 ±0.62 and 
3.45 mm2 ±0.57, respectively). Although the ethanol group appeared to have a smaller 
cross-sectional area in this bone region, no significant difference were observed from 
the controls (p=1.15) (Fig. 3.13). The distal medullary canal appear small in the ethanol 
group (1.49 mm2 ±0.35) in comparison to the saline and untreated controls (1.71 mm2 
±0.38 and 1.82 mm2 ±0.57, respectively). These differences were only significantly 
different between the ethanol group and untreated control (p=0.03) (Fig. 3.14). With 
respect to cortical area (thickness) in this bone region, the ethanol group (1.61 mm2 
±0.34) exhibited a marginally lower value compared to the saline and untreated controls 
(1.66mm2 ±0.89 and 1.63 mm2 ±0.55, respectively). Again, no significant differences 
were observed (p=0.17) (Fig. 3.15). 
 
 
 
 
 
 
Figure 3.13: Distal cross sectional area. The mean cortical area at the 75th percentile mark is 
given for the three groups studied. Error bars represent standard deviation. 
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Figure 3.14: Distal medullary canal area. The mean medullary canal area at the 75th percentile 
mark is given for the three groups studied. Error bars represent standard deviation, and a line 
connects group with significance difference from the ethnaol group. 
 
 
 
Figure 3.15: Distal cortical area. The mean cortical area at the 75th percentile mark is given for 
the three groups studied. Error bars represent standard deviation. 
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3.7.4 Relationship of cross-sectional area with cortical thickness and medullary 
thickness 
In the midshaft, the cross-sectional area for the ethanol group was highly correlated with 
the medullary canal area (R=0.612, p=0.002) and cortical thickness (R=0.784, p=<0.001) 
(Table 3.2). This pattern of high correlation also occurred in the saline group with the 
midshaft cross sectional area being correlated with the medullary canal area (R=0.849, 
p=<0.001) and cortical thickness (R=0.942, p=<0.001) (Table 3.2). 
In the distal region, the cross-sectional area for the ethanol group was also highly 
correlated with the medullary canal area (R=0.854, p=<0.001) and cortical thickness 
(R=0.833, p=<0.001) (Table 3.2). A similar pattern was observed in the saline control 
medullary canal area (R=0.782, p=<0.001) and cortical thickness (R=0.742, p=<0.001) 
(Table 3.2).  
 
Table 3.2: Pearson’s correlation of cross sectional area with cortical thickness and medullary 
thickness in the ethanol group and saline controls 
 
 
 
  
Ethanol Saline Control  
Medullary 
Canal Area 
Cortical 
Thickness 
Medullary 
Canal Area 
Cortical 
Thickness 
Midshaft  
Cross Sectional 
Area 
Correlation 0.612 0.784 0.849 0.942 
p value 0.002 <0.001 <0.001 <0.001 
N 22 22 21 21 
Distal Cross-
Sectional Area 
Correlation 0.854 0.833 0.782 0.742 
p value <0.001 <0.001 <0.001 <0.001 
N 22 22 24 24 
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3.7.5 Relationship of osteometric and trabecular morphometric parameters 
In the ethanol group, full bone length was highly correlated with shaft length (R=0.864, 
<0.001) and distal volume (R=0.723, p=0.002) (Table 3.3). This high correlation of full 
bone length with shaft length (R=0.788, <0.001) and distal volume (R=0.534, p=0.001) 
was also observed in the saline control group (Table 3.4). There was no correlation of 
either full bone or shaft length with trabecular properties in both the ethanol and saline 
group (Table 3.3). However, shaft length was correlated with distal volume in both the 
ethanol (R = 0.664, p =0.005) and saline control group (R = 0.447, p =0.032) (Table 3.4). 
There was also a strong correlation of distal volume with bone to total volume ratio 
(BV/TV) (R=0.731, p=0.002) and thickness (TbTh) (R=0.840, p=0.032) in the ethanol group 
(Table 3.3). This pattern of correlation of distal volume with bone to total volume ratio 
(BV/TV) (R=0.731, p=0.002) and trabecular thickness (TbTh) (R=0.747, p<0.001) also 
occurred in the saline controls (Table 3.4). However, in the ethanol group, the distal 
volume was negatively correlated with trabecular number (TbN) (R=-0.777, p<0.001) 
(Table 3.3). On the other hand, the saline group showed that trabecular thickness (TbTh) 
(R=0.747, p<0.001) and trabecular were also correlated (TbN) (R=0.450, p<0.031) (Table 
3.4).    
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Table 3.3: Pearson’s correlation of osteometric as well as trabecular morphometric parameters 
in the ethanol group. 
 
 
 
 
    Full 
Bone 
Length 
Shaft 
Length 
Distal 
Volume 
BV/TV 
Distal 
TbTh 
Distal 
TbN 
Distal 
TbSp 
Distal 
Full 
Bone 
Length 
 
Correlation 
1 0.864 0.723 0.370 0.459 -0.424 -0.283 
P value   <0.001 0.002 0.174 0.086 0.116 0.306 
N 16 16 16 15 15 15 15 
Shaft 
Length 
 
Correlation 
0.864 1 0.664 0.388 0.426 -0.319 -0.193 
P value <0.001   0.005 0.153 0.114 0.246 0.492 
N 16 16 16 15 15 15 15 
Distal 
Volume 
 
Correlation 
0.723 0.664 1 0.731 0.840 -0.777 -0.241 
P value 0.002 0.005   0.002 <0.001 0.001 0.386 
N 16 16 16 15 15 15 15 
BV/TV 
Distal 
 
Correlation 
0.370 0.388 0.731 1 0.739 -0.615 -0.238 
P value 0.174 0.153 0.002   <0.001 0.004 0.327 
N 15 15 15 20 20 20 19 
TbTh 
Distal 
 
Correlation 
0.459 0.426 0.840 0.739 1 -0.840 -0.458 
P value 0.086 0.114 <0.001 <0.001   <0.001 0.049 
N 15 15 15 20 20 20 19 
TbN 
Distal 
 
Correlation 
-0.424 -0.319 -0.777 -0.615 -0.840 1 0.385 
P value 0.116 0.246 0.001 0.004 <0.001   0.104 
N 15 15 15 20 20 20 19 
TbSp 
Distal 
 
Correlation 
-0.283 -0.193 -0.241 -0.238 -0.458 0.385 1 
P value 0.306 0.492 0.386 0.327 0.049 0.104   
N 15 15 15 19 19 19 19 
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Table 3.4: Pearson’s correlation of osteometric and trabecular morphometric parameters in 
the saline controls. 
 
 
 
 
 
 
 
    Full Bone 
Length 
Shaft 
Length 
Distal 
Volume 
BV/TV 
Distal 
TbTh 
Distal 
TbN 
Distal 
TbSp 
Distal 
Full 
Bone 
Length 
 Correlation 1 0.788 0.534 -0.413 -0.419 0.000 0.003 
P value   <0.001 0.011 0.056 0.052 0.999 0.988 
N 22 22 22 22 22 22 22 
Shaft 
Length 
 Correlation 0.788 1 0.447 -0.286 -0.179 0.152 0.029 
P value <0.001   0.032 0.186 0.414 0.489 0.896 
N 22 24 23 23 23 23 23 
Distal 
Volume 
 Correlation 0.534 0.447 1 0.293 0.053 0.274 0.089 
P value 0.011 0.032   0.174 0.810 0.206 0.687 
N 22 23 23 23 23 23 23 
BV/TV 
Distal 
 Correlation -0.413 -0.286 0.293 1 0.747 0.348 0.137 
P value 0.056 0.186 0.174   <0.001 0.104 0.533 
N 22 23 23 23 23 23 23 
TbTh 
Distal 
 Correlation -0.419 -0.179 0.053 0.747 1 0.450 0.269 
P value 0.052 0.414 0.810 <0.001   0.031 0.214 
N 22 23 23 23 23 23 23 
TbN 
Distal 
 Correlation 0.000 0.152 0.274 0.348 0.450 1 -0.126 
P value 0.999 0.489 0.206 0.104 0.031   0.567 
N 22 23 23 23 23 23 23 
TbSp 
Distal 
 Correlation 0.003 0.029 0.089 0.137 0.269 -0.126 1 
P value 0.988 0.896 0.687 0.533 0.214 0.567   
N 22 23 23 23 23 23 23 
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3.8 Prediction of group membership using the cortical and medullary canal areas 
A binary logistic regression analysis was conducted to predict membership to either the 
ethanol or saline control group using cortical area (thickness) and medullary canal area 
as predicting variables. A test of the full model against a constant only model was 
statistically significant, indicating that the predictors as a set reliably distinguished 
between ethanol and saline control group membership (Chi square = 17.608, p = 0.007 
with df = 6). Nagelkerke’s R2 of 0.487 indicated a moderately strong relationship between 
prediction and grouping. The Wald criterion demonstrated that only the distal medullary 
canal area made a significant contribution to prediction of group membership (p =0.0120 
(Table 3.5). Prediction success overall was 74.4% (72.7% for the ethanol group and 76.2% 
saline controls (Table 3.6). 
 
Table 3.5: Cortical and medullary canal area variables in the equation.  
                                                   Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 
Midshaft Medullary Area 0.219 2.774 0.006 1 0.937 1.244 
Midshaft Cortical Thickness 3.955 3.691 1.148 1 0.284 52.196 
Distal Medullary Area 4.576 1.814 6.365 1 0.012 97.161 
Distal Cortical Thickness -3.544 2.786 1.618 1 0.203 0.029 
Constant -0.422 2.608 0.026 1 0.872 0.656 
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Table 3.6: Group membership classification from cortical and medullary canal area variables. 
Classification Table 
Observed 
Predicted 
Group Percentage 
Correct Ethanol Saline Control 
Group 
Ethanol 16 6 72.7 
Saline Control 5 16 76.2 
Overall Percentage   74.4 
 
3.9 Prediction of group membership using the trabecular morphometric parameters 
A binary logistic regression analysis was conducted to predict membership to either the 
ethanol or saline control group using bone volume to total volume ratio, trabecular 
thickness, number and separation as predicting variables. A test of the full model against 
a constant only model was statistically significant, indicating that the predictors as a set 
reliably distinguished between ethanol and saline control group membership (Chi square 
= 23.748, p < 0.001 with df = 4). Nagelkerke’s R2 of 0.577 indicated a moderately strong 
relationship between prediction and grouping. The Wald criterion demonstrated that 
only trabecular spacing (TbSp) predict membership (Table 3.7). Prediction success overall 
was 78.6% (84.2% for the ethanol group and 73.9% saline controls) (Table 3.8). 
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Table 3.7: Trabecular morphometric variables in the equation. 
                          Variables in the Equation 
 B S.E. Wald Df Sig. Exp(B) 
BV/TV Distal 10.212 6.094 2.808 1 0.094 27238.4 
TbTh Distal 7.822 10.542 0.551 1 0.458 2494.944 
TbN Distal 0.685 0.423 2.619 1 0.106 1.984 
TbSp Distal 41.665 16.795 6.155 1 0.013 12438520 
Constant -14.685 5.475 7.194 1 0.007 0 
 
 
 
 Table 3.8: Group membership classification from trabecular morphometric parameters. 
Classification Table 
Observed 
Predicted 
Group 
Percentage Correct 
Ethanol Saline Control 
Group 
Ethanol 16 3 84.2 
Saline Control 6 17 73.9 
Overall Percentage   78.6 
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4 DISCUSSION 
4.1 Rat model of fetal alcohol syndrome  
In the current study, a model of moderate binge drinking was utilized. This model is 
appropriate in the South African context as reports exist in the literature showing that 
some women tend to take massive amounts of alcohol within a short duration (binge 
drinking) (Conover and Jones, 2012). This is due to the stigma associated with alcohol 
consumption by females in certain communities. The high level of basic health illiteracy 
also contributes to alcohol intake during pregnancy although many women stop drinking 
once they know that they are pregnant. 
The use of untreated control intends to rule out the potential effects of stress as 
treatment was through oral gavage, which may elevate stress levels and possibly affect 
pregnancy. Daily dosing of ethanol mimic regular binge drinking. As alcohol has more 
calories than rat feed, we expected the ethanol treated animals to either gain more 
weight than controls or to consume less food or both. However, we found that weight 
gain and food consumption were similar in all three study groups. 
While the level of blood alcohol was elevated, as measured an hour following treatment, 
a major concern was that rats metabolize alcohol faster than humans as the peak blood 
ethanol concentration in rodents occurs an hour after administration. Normal blood 
alcohol levels are exhibited two hours after treatment (Snow and Keiver, 2007). The 
dosing frequency effectively means that the fetus would be exposed to alcohol for a 
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limited time (approximately 2 hours) daily. This could potentially impact on the ability to 
induce gestational alcohol exposure effects.  
We chose a dose of 25.2% ethanol in light of the fact that a lower dose could potentially 
fail to induce the intended effect on the offspring. A higher dose could increase the risk 
of failed implantations and spontaneous abortions. Reports suggest that prenatal alcohol 
may result in still births, self-abortion and resorption, and this may result in fewer pups 
born in the ethanol group (Abel and Dintcheff, 1978; Simpson et al., 2005; Snow and 
Keiver, 2007). In the present study, no significant differences were observed in litter size 
and gestation duration although the ethanol group had fewer pups. This suggests that 
the dose and frequency of ethanol administration employed in this study did not produce 
any observable effect on the gestation duration and litter size due to lack of statistical 
significance observed among the groups.  
4.2 Prenatal alcohol exposure effects on distal tibia growth plate 
 Growth plate surface area 
Alcohol has been shown to cause changes in the growth plate resulting in a delay in bone 
development (Miralles-Flores and Delgado-Baeza, 1992). In agreement with this, the 
growth plate exhibited a smaller surface area in comparison with the controls in the 
present study.  It is possible that the smaller growth plate area in the alcohol group may 
be a contributing factor in the delayed growth in FAS children. 
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Proliferative zone surface area and cell count 
In the proliferative zone of the growth plate, we found both fewer cells and a smaller 
surface area in the ethanol treated group compared to the saline and untreated controls. 
As the growth plate is responsible for longitudinal growth (Nilsson and Baron, 2004; Lui 
et al., 2011), this could be one of the reasons for the shorter stature exhibited by children 
with FAS. Miralles-Flores and Delgado-Baeza (1992) investigated the effects of 
gestational alcohol exposure on 0 and 15 day postnatal pups. Changes in the growth 
plate were only shown on the later but not on the former. However, Snow and Keiver 
(2007) found that gestational alcohol affected pups that were surgically removed at 21 
days of gestation. Our results corroborate the report of Snow and Keiver (2007). This 
could be attributed to the duration of alcohol exposure. In their study, alcohol was 
adminitered three weeks before gestation and three weeks during preganacy.  
The ethanol group exhibited fewer cell number and proliferating chondrocytes when 
compared with the untreated group. The mechanisms in which alcohol affects the 
proliferative cells are unknown. It is possible that alcohol disturbs cell chondrocyte 
proliferation in one or more of the cell division phases, resulting in slow proliferation 
rate. Another possibility is induction of apoptosis, due to a potential DNA damage caused 
by the teratogenic effects of alcohol or by impaired hormonal regulation of bone 
metabolism. Further studies are required to ascertain these theories. 
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Hypertrophic zone surface area and cell count  
The hypertrophic zone comprises chondrocytes that are older and larger than the 
chondrocytes found in the proliferative zone. The more mature cells are located closer 
to the diaphyseal end of the plate. In the hypertrophic zone, lipids, glycogen, and alkaline 
phosphatase accumulate, resulting in the calcification of the cartilaginous matrix. The 
longitudinal growth of bone is a result of cellular division in the proliferative zone along 
with the maturation of cells in the hypertrophic zone. Although no significant differences 
were observed between the cell count and the surface area of the hypertrophic zone, 
differences have been documented in studies by Snow and Keiver (2007), which showed 
an increase in the surface area of the hypertrophic zone. Differences in findings could be 
attributed to the ages of the rat pups used, our study reported on the tibial length of 
postnatal 3 week old pups in comparison to previous reports, in these studies the rat 
pups were aged 21 day gestation and 0 as well as 15 days postnatal, respectively 
(Miralles-Flores and Delgado-Baeza, 1992; Snow and Keiver, 2007). The ethanol group 
exhibited less Ki-67 labelled cells and proliferating chondrocytes when compared with 
the saline and the untreated groups. The differences noted may be attributed to the 
same factors that might have affected the cellular proliferation in the proliferative zone. 
The differences reported may also have been due to differences in the ages of the rats, 
since the regulation of bone development varies between pre and postnatal 
development. Likewise, this may be attributed to the effect of in utero ethanol exposure 
on the expression of local growth factors and systemic hormones which affect osseous 
tissue development differently during pre and postnatal periods. Furthermore, 
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differences between the duration of alcohol exposure in the studies may account for the 
differences reported in the hypertrophic zone.  It is clear that research in this area is 
limited with only two studies focusing on the effects of prenatal alcohol on longitudinal 
growth. Insight into how the epiphyseal plate is affected by gestational alcohol could 
provide valuable information in paving the way for appropriate treatment regimens to 
combat this devastating impact on growth. 
4.3 Osteometric and bone internal morphology  
Bone length 
The full and shaft length of the tibia were similar among all three groups in the study. In 
contrast, previous studies found shorter tibiae in the ethanol group (Miralles-Flores and 
Delgado-Baeza, 1992; Simpson et al., 2005; Snow and Keiver, 2007). In the present study, 
we used 25.2% ethanol whereas other researchers used a higher ethanol concentration 
of 36% (Miralles-Flores and Delgado-Baeza, 1992; Simpson et al., 2005; Snow and Keiver, 
2007). The effects of prenatal ethanol exposure on bone are dose dependent as Simpson 
et al. (2005) and Snow and Keiver. (2007) showed that 36% ethanol has more adverse 
effects on bone than 25% and 15% ethanol administered in gestation. A possibility exists 
that we could have found a shorter length had we used a higher concentration such as 
36%. 
The gestation duration in our study could have contributed to the similar bone lengths 
we observed as we allowed the dams to litter naturally resulting in a gestation range of 
19-24 days. However, there was no statistical significance in gestation duration in our 
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study. Other researchers controlled for variation in gestation duration by surgically 
removing the pups at 21 days gestation. Since treatment was stopped at gestation day 
19, some litters may have had an intrauterine recovery period between end of treatment 
and term (birth) (Miralles-Flores and Delgado-Baeza, 1992; Snow and Keiver, 2007).  
Considering the relatively high rate of alcohol metabolism in rats, these animals in our 
study were only exposed to ethanol for approximately 2 hours per day, as that is the time 
it takes for rodents to metabolise ethanol (Simpson et al., 2005; Snow and Keiver, 2007). 
This, combined with the moderate dose of 25.2% ethanol could have possibly spared the 
animals from more noticeable effects.   
These results could potentially be different in humans as most people who drink during 
pregnancy are less educated and also have lower socioeconomic status, which impacts 
their diet (May et al., 2013). As the animals were on a nutritious balanced diet, and this 
could have mitigated the effects of ethanol. Additionally, there was a 3-week postnatal 
period of no ethanol exposure which may have improved the chances of recovery in 
some respects such as bone length.  Spohr et al. (1993) and Streissguth et al. (1991) 
suggested that that there is potential for catch up growth following prenatal exposure 
to ethanol. This proposition requires further studies to establish the facts.  
Trabecular bone 
In the present study, we found both lower bone volume to total volume (BV/TV) and 
trabecular thickness (TbTh) to be lower in the ethanol group in comparison with the 
controls. This finding is similar to previous reports using growing rats (Sampson et al., 
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1996; Sampson et al., 1997) and in adult rats (Diamond et al., 1989; Wezeman et al., 
1999; Turner et al., 2001; Maddalozzo et al., 2009) showing that alcohol intake reduces 
trabecular bone volume and aids trabecular thinning. Children with FAS have a higher 
risk of osteoporosis (Jones and Dwyer, 2000b; Cooper et al., 2001). Osteoporosis is a 
skeletal disease, characterised by reduction in bone mass and disruption of trabecular 
and compact bone structure, resulting in loss of mechanical strength and an increased 
fracture risk (Soares et al., 2010). These features are observed in alcohol fed rats 
(Wezeman et al., 1999; Hogan et al., 1997) and in young, growing rats (Sampson et al., 
1996). Similarly, Chen et al. (2001) found a decrease in trabecular number in the hamster 
femur following alcohol consumption. This is thought to be due to a decrease in the 
osteoblast number and size as previously reported in alcohol exposed rats (Diez et al., 
1997). 
Having not seen differences in bone length among the three groups, we queried whether 
a size estimation method that includes more dimensions would yield the same 
observations. Linear measurements such as length are in a single dimension and as such 
tend to exclude size information from other dimensions in three-dimensional space. We 
then calculated the distal volume (part below the growth plate), as this is the portion 
rich in trabeculae. We found that the distal volume was significantly less in the ethanol 
group compared to the controls despite similar bone lengths. This finding suggests that 
alcohol affects the distal volume. 
The trabecular number (TbN) was not affected in our study. This is similar to the findings 
of Maddalozzo et al. (2009), who did not find any changes on the TbN in the distal tibial 
 
 
 
89 
 
epiphysis.  In their study, 4 weeks old rats were fed over a period of 3 month with 35%. 
The abnormality may be associated with alcohol induced caloric restriction in their study. 
There was more trabecular spacing in the ethanol group. This, considered together with 
the lower BV/TV and TbTh suggests that, although the bone length was similar in all 
groups, the internal morphology was not the same among the study groups. This 
indicates that prenatal alcohol exposure at our dosage may affect internal architecture 
while sparing the external bone length. This disruption of the internal bone morphology 
may also explain why FAS children are prone to osteoporosis and fracture as they may 
have less bony material internally.  
Cortical thickness and medullary canal area 
Cortical bone is the most important factor of bone strength (Maurel et al., 2012). Two 
studies evaluated the deleterious effect of alcohol intake on cortical bone of rodents. 
These studies presented negative alterations on the thickness and porosity of the bone 
(Hogan et al., 1997; Maurel et al., 2012).  
4.4 Parameters most affected by prenatal ethanol exposure 
Employing a binary logistic regression showed that the distal medullary canal area and 
trabecular spacing were the main parameters that determined group membership into 
either ethanol treated or saline control. This means that these two parameters (distal 
medullary canal area and trabecular spacing) are affected the most in gestational alcohol 
exposure. 
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Our finding of a positive correlation between medullary canal area and cortical thickness 
indicates that the smaller medullary canal was coupled with thinner cortical bone. We 
propose that this may potentially explain weaker bones observed in FAS children.  
The negative correlation of trabecular thickness and spacing in the ethanol group 
indicates that thin trabecular occurred with more spacing in between. This would 
contribute to bone weakness.  Our findings add light to the question of how osteoporosis 
and subsequent propensity to fracture may occur in prenatal alcohol exposure. 
4.5 Conclusion 
Gestational alcohol exposure had an adverse effect on the proliferating chondrocytes 
that resulted to the reduction in size and surface area of both the proliferative and 
hypertrophic zones. This may be how diminished stature of the offspring occurs. Fewer 
proliferative cells were found using the anti-Ki67 antibody, indicating that in utero 
alcohol exposure slows cell proliferation, contributing to the small stature.  
Logistic regression showed that the distal medullary canal area and trabecular separation 
were the main parameters affected the most by gestational alcohol. The negative 
correlation of trabecular thickness and spacing in the ethanol group may be a contributor 
to bone weakness. These findings add new knowledge to how in utero alcohol exposure 
affects the offspring. 
4.6 Limitations of the study  
Endocrine parameters that control bone formation such as parathyroid hormone have 
not been included in the study. Our study excluded bone strength parameters due to the 
 
 
 
91 
 
time constraints. The untreated group had a smaller sample size which affected the 
analysis.  
4.7 Recommendations 
In this work, more questions have been raised form the available findings. It would 
therefore be of great importance to further characterise these findings. More work 
should be put in place to evaluate a specific mechanism by which prenatal alcohol 
exposure can result to pre and postnatal growth retardation. Understanding this 
mechanism would be helpful in predicting the effects of various alcohol concentration 
on pre and postnatal growth development following in utero exposure, as well as other 
teratogenic agents. Areas of interest would be via the direct and indirect mechanisms 
that control bone growth and development as well as other immunological mechanisms 
(receptor-mediated and regulation of cellular metabolism). Answers to these questions 
would help to substantiate the findings in this work and would provide the knowledge 
that is still lacking today. 
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APPENDICES  
Appendix 1: Turnitin report 
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APPENDIX 2: Ethical clearance certificate 
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Appendix 3: Preparation of 10% neutral buffered formalin (10% NBF) 
For 1000mls 
1. Measure 900mls of distilled water 
2. Add 9g of NaCl 
3. Add 12g of Na2HPO4 
4. Place in a beaker and stir using magnetic stirrer until clear 
5. Add 10ml of formalin  
6. Store at room temperature 
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Appendix 4: Determination of blood ethanol concentration 
1. Dilute samples with assay buffer (1:10 dilution) in a clean test tubes. 
2. Prepare Reaction Mix (46µl Ethanol assay buffer, 2µl Ethanol probe, and 2µl 
Ethanol Enzyme Mix) 
3. Add 50µl of the Reaction Mix to all the test tubes 
4.  Incubate for 60 minutes at room temperature in a dark environment. 
5. Measure O.D. 570nm 
6. Correct background (difference of background value derived from the 0 ethanol 
control from all the samples) 
7. Calculate ethanol concentration from the standard curve, multiplied by the 
dilution factor. 
C = Sa/Sv nmol/µl or mM          
Where:           Sa = sample amount from the Standard Curve (nmol)   
                        Sv = sample volume added into the samples (µl) 
                        Ethanol molecular weight: 46.07g/mol     
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Appendix 5: Tissue decalcification 
Methods 
1. Put tissue samples in cassettes and immerse in slowly running tap water for 30 
minutes 
2. Put tissue samples in EDTA for 3 weeks 
3. Put tissue sections in running tap water for 30 minutes 
  
 
 
 
97 
 
Appendix 6: Decalcification end point 
Methods 
1 Take 5mls of EDTA in to separate test tube 
2. Add 10mls ammonium oxalate 
3. Mix well and allow to stand overnight 
4. Examine for precipitate 
5. Repeat if there is precipitate until when clear 
6. Rinse in running tap water if no precipitate 
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Appendix 7: Tissue Processing 
The tissue was processed using an automatic tissue processor (Shandon citadel 1000) 
as follows: 
1. 10% buffered formalin for 4 hours  
2. 70% alcohol for 1 hour 
3. 95% alcohol for 2 hours 
4. 95% alcohol for 2 hours 
5. 95% alcohol for 2 hours 
6. 95% alcohol for 2 hours 
7. 100% alcohol for 2 hours 
8. 100% alcohol for 2 hours 
9. 100% alcohol for 2 hours 
10. Chloroform for 2 hours 
11. Chloroform for 2 hours 
12. Wax for 2 hours 
13. Wax for 2 hours 
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Appendix 8: Paraffin embedding 
1. Warm the wax as well as the metal molds and a pair of forceps making sure that the           
temperature does not exceed 60oC. 
2. Once the wax has melted, fill the metal mold with wax. 
3. Using the warmed forcep, gently orient the specimens such that the anterior surface 
of the distal end faces the floor of the mold. 
4. Cool briefly, and then cover with the plastic cassette accordingly. 
5. Quickly top up with more melted wax and cool for approximately 20 minutes. 
6. Separate the metal mold from the plastic cassette. 
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Appendix 9: Silane coated slides 
APES solution 
1. 3-aminopropytriethoxysilane                                      4mls 
2. Acetone                                                                           200mls 
Methods 
1. Immerse slides in APES solution 
2. Rinse 2x in acetone for 10 dips 
3. Rinse 2x in distilled water for 10 dips 
4. Air dry at angle of 45 degrees 
5. Incubate at 37 degrees overnight 
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Appendix 10: Staining of tissue sections 
Appendix 10.1: Haematoxylin and eosin staining 
Haematoxylin solution 
For 1000mls 
1. Haematoxylin                                                                        1g 
2. Aluminium potassium sulphate (Potassium alum)        50g 
3. Sodium iodate                                                                       0.2g 
4. Citric acid                                                                                1g 
5. Chlorate hydrate                                                                   50g 
6. Allow haematoxylin, alum and sodium iodate to dissolve overnight. 
7. Add chloral hydrate and citric acid  
8. Boil solution for 5 minutes and then allow to cool. 
Eosin solution  
For 1000mls  
1. Measure 1000mls of distilled 
2. Add 8g of stock eosin 
3. Add 2g of erythron 
4. Stir using a magnetic stirrer 
Methods 
Hydration 
1. Dewax in xylene for 2x10 minutes. 
2. Immerse in 2 changes of 100% ethanol for 3 minutes each 
3. Immerse in 95% ethanol for 3 minutes 
4. Immerse in 70% ethanol for 3 minutes 
5. Wash in distilled water for 5 minutes 
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Nuclear staining 
1. Stain with Mayer’s haematoxylin for 10 minutes 
2. Wash in running tap water for 2 minutes 
3. Differentiate in 1% acid alcohol for 2 dips 
4. Wash in running tap water for 2 minutes 
5. Blue in Scott’s tap water for 2 minutes 
6. Wash in running tap water for 2 minutes 
Cytoplasm staining 
1. Stain in eosin for 2 minutes 
2. Wash briefly in running tap water 
Dehydration and mounting 
1. Immerse in 70% ethanol for 3 minutes 
2. Immerse in 90% ethanol for 10 minutes 
3. Immerse in 100% ethanol for 10 minutes 
4. Clear in 2 changes of xylene 
5. Mount in entellen 
Results 
Nuclei: Blue-black 
Muscle fibers: deep pinky red 
Cytoplasm: Varying shades of pink. 
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Appendix 10.2: Scott’s tap water solutions 
For 100mls 
1. Sodium hydrogen carbonate                                   2g 
2. Magnesium sulphate                                                20g 
3. Distilled water                                                            1000mls 
Dissolve the salts in the water and store in stock solutions at room temperature. 
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Appendix 10.3: Immunohistochemistry 
Sodium citrate buffer (pH 6.0) solution 
For 100ml 
Tri- sodium citrate (dehydrate).                2.9g 
Distilled water                                              1000ml 
Mix to dissolve sodium citrate and adjust pH to 6 with 1ml HCl 
Tween 20                                                       0.5ml 
Phosphate buffer (pH=7.0) solution 
For 2000ml 
NaCl                                                                16g 
Na2HPO4                                                         3.5g 
KCl                                                                  0.4g 
KH2PO4                                                            0.4g 
Distilled water                                              2000ml 
DAB working solution 
DAB chromogen                                           50µl 
Substrate (hydrogen peroxide)                250µl 
Primary antibody (Ki-67) dilution factor 1:1200 
Phosphate buffer                                         1200µl 
Ki-67                                                               1µl 
 
 
 
105 
 
Remove 1 µ from phosphate buffer and replace with 1200µl of Ki-67 antibody 
Methods 
Day 1 
1. Deparaffinise sections in xylene for 2x 10 minutes 
2. Rehydrate sections through graded alcohols 
3. Wash slides in running tap water for 5 minutes  
4. Antigen retrieve sections in citrate buffer PH 6 (water bath) overnight at 60o 
Day 2 
5. Allow to cool at room temperature for 20 minutes 
6. Wash slides in running tap water for 5 minutes 
7. Block endogenous peroxidase with 1% H2O2 in methanol for 10 minutes 
8. Wash in phosphate buffer solution (PBS) (PH 7.4) for 3x 5 minutes 
9. Incubate with normal goat serum 5% (protein block) for 10 minutes 
10. Tap serum off slides and wash in PBS for 3x 5 minutes 
11. Incubate with primary antibody (Ki-67 1:1200) over night at 4oC 
Day 3 
12. Allow sections to reach room temperature for 20 minutes 
13. Wash in PBS (pH=7.4) for 3x 5 minutes  
14. Incubate with biotinylated secondary antibody 3x 5 minutes 
15. Wash in PBS for 3x 5 minutes 
16. Incubate with Strep Avidin HRP for 10 minutes 
17. Wash in PBS for 3x 5 minutes 
18. Incubate with DAB working solution for 5 minutes 
19. Rinse in running tap water for 5 minutes 
20. Blue with Scott’s tap water for 2 minutes  
21. Wash in running tap water for 5 minutes  
22. Hydrate through graded alcohol 
23. Clear in xylene and mount with entellen  
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Appendix 11: Cells count 
1.  Import image in to image J (file > open) 
2. Go to image on the software and click on image > type > 8 bit 
3. Click on process > subtract background and adjust pixel size to 12 
4. Click on image > adjust > threshold > apply 
5. Click on process > binary > fill holes 
6. Click on process > binary > convert to mask 
7. Click on process > binary > watershed 
8. Click on polygonal selection tool and demarcate region of interest 
9. Click on analyse > analyse particles 
10.  Select bare outline and summarise result on the popped up window 
11. Click “OK”  
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Appendix 12: Measurement of cortical thickness 
1. Import image (file > open 
2. Select line tool and draw a line along the entire length of the scale bar 
3. Select analyse > set scale 
4. Type the known distance 2 and the unit of length (mm) in the box that 
appeared 
5. Check on the global and click “OK” 
6. Select analyse > tools > ROI manager. A window will appear 
7. Select polygonal selection tool 
8. Delineate the cross sectional area  
9. Click add on the ROI manager 
10. Delineate the medullary area 
11. Click add on the ROI manager 
12. Click measure and calculate the difference   
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